RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | bile duct disease |
|
Accession: | DOID:4138
|
browse the term
|
Definition: | A biliary tract disease located_in one or more bile ducts. (DO) |
Synonyms: | exact_synonym: | bile duct diseases; bile duct disorder; disorder of bile duct |
| narrow_synonym: | Non-Neoplastic Bile Duct Disorder |
| primary_id: | MESH:D001649 |
| xref: | EFO:1000400; NCI:C96716 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
GViewer not supported for the selected species.
|
|
G |
F3 |
coagulation factor III, tissue factor |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:21037076 |
RGD:11341737 |
NCBI chrNW_004955423:254,060...264,448
Ensembl chrNW_004955423:254,189...264,159
|
|
G |
Fech |
ferrochelatase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10464147 |
|
NCBI chrNW_004955402:41,902,868...41,938,099
Ensembl chrNW_004955402:41,902,868...41,938,174
|
|
G |
Magee1 |
MAGE family member E1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30515189 |
|
NCBI chrNW_004955557:60,440...170,159
|
|
|
G |
Unc45a |
unc-45 myosin chaperone A |
|
ISO |
ClinVar Annotator: match by term: Cholestasis-edema syndrome, Norwegian type |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955416:14,999,692...15,012,581
Ensembl chrNW_004955416:14,999,375...15,012,581
|
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome 1 | ClinVar Annotator: match by term: Alagille syndrome 2 | ClinVar Annotator: match by term: Arteriohepatic dysplasia ClinVar Annotator: match by term: Arteriohepatic dysplasia | ClinVar Annotator: match by term: HEPATIC DUCTULAR HYPOPLASIA, SYNDROMATIC ClinVar Annotator: match by term: Alagille syndrome 1 | ClinVar Annotator: match by term: Arteriohepatic dysplasia |
ClinVar |
PMID:9207787 PMID:9207788 PMID:9536098 PMID:9585603 PMID:9700188 PMID:10213047 PMID:10220506 PMID:10533065 PMID:11058898 PMID:11139239 PMID:11139247 PMID:11152664 PMID:11157803 PMID:11180599 PMID:11259677 PMID:12022040 PMID:12239725 PMID:12244555 PMID:12297837 PMID:12442286 PMID:12497640 PMID:12649809 PMID:15358557 PMID:15712272 PMID:15772854 PMID:15990638 PMID:16199547 PMID:16575836 PMID:16875832 PMID:17241866 PMID:17576681 PMID:17720887 PMID:17949281 PMID:18660822 PMID:19058200 PMID:19780835 PMID:19948535 PMID:20301450 PMID:20437614 PMID:20586101 PMID:21752016 PMID:22040217 PMID:22382802 PMID:22405927 PMID:22487239 PMID:22488849 PMID:22759690 PMID:23891399 PMID:23956173 PMID:24033266 PMID:24748328 PMID:25260786 PMID:25326637 PMID:25525159 PMID:25606387 PMID:25676721 PMID:25741868 PMID:26076142 PMID:26548814 PMID:26633542 PMID:26760175 PMID:26785492 PMID:27256232 PMID:27760138 PMID:28166811 PMID:28372585 PMID:28492532 PMID:28695677 PMID:29187043 PMID:29483232 PMID:29555955 PMID:29707407 PMID:29783821 PMID:30074189 PMID:30293987 PMID:30651579 PMID:31343788 PMID:31475041 PMID:31595668 PMID:32065591 PMID:32733715 PMID:33433009 PMID:33532864 PMID:34071626 PMID:34150014 PMID:34185059 PMID:34399559 PMID:34746741 PMID:36973604 PMID:37600608 More...
|
|
NCBI chrNW_004955415:20,490,414...20,526,068
Ensembl chrNW_004955415:20,490,414...20,527,917
|
|
G |
Notch2 |
notch receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome 1 | ClinVar Annotator: match by term: Alagille syndrome 2 |
ClinVar |
PMID:16773578 PMID:24728327 PMID:25016221 PMID:25741868 PMID:28492532 PMID:28512196 PMID:28566479 PMID:28776642 PMID:28941602 PMID:31749841 More...
|
|
NCBI chrNW_004955568:1,660,357...1,812,285
Ensembl chrNW_004955568:1,660,731...1,809,173
|
|
|
G |
Ankef1 |
ankyrin repeat and EF-hand domain containing 1 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:19,967,234...19,988,725
Ensembl chrNW_004955415:19,967,234...19,993,481
|
|
G |
Hao1 |
hydroxyacid oxidase 1 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:17,981,791...18,035,151
Ensembl chrNW_004955415:17,981,791...18,035,224
|
|
G |
Jag1 |
jagged canonical Notch ligand 1 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome 1 | ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
OMIM ClinVar |
PMID:9207787 PMID:9207788 PMID:9536098 PMID:9585603 PMID:9700188 PMID:10213047 PMID:10220506 PMID:10533065 PMID:11058898 PMID:11139239 PMID:11139247 PMID:11152664 PMID:11157803 PMID:11180599 PMID:11181574 PMID:11259677 PMID:12022040 PMID:12239725 PMID:12244555 PMID:12442286 PMID:12497640 PMID:12649809 PMID:15358557 PMID:15712272 PMID:15772854 PMID:15990638 PMID:16199547 PMID:16575836 PMID:16875832 PMID:17241866 PMID:17576681 PMID:17720887 PMID:17949281 PMID:18660822 PMID:19058200 PMID:19780835 PMID:19948535 PMID:20301450 PMID:20437614 PMID:21752016 PMID:22040217 PMID:22382802 PMID:22405927 PMID:22487239 PMID:22488849 PMID:22759690 PMID:23891399 PMID:23956173 PMID:24033266 PMID:24684524 PMID:24748328 PMID:25260786 PMID:25525159 PMID:25606387 PMID:25676721 PMID:25741868 PMID:26076142 PMID:26548814 PMID:26633542 PMID:26760175 PMID:26785492 PMID:27256232 PMID:27760138 PMID:28492532 PMID:28695677 PMID:29187043 PMID:29453956 PMID:29483232 PMID:29555955 PMID:29707407 PMID:29783821 PMID:30074189 PMID:30293987 PMID:31343788 PMID:31475041 PMID:31595668 PMID:32065591 PMID:32733715 PMID:33433009 PMID:33532864 PMID:34071626 PMID:34150014 PMID:34185059 PMID:34399559 PMID:34746741 PMID:36474027 PMID:36973604 PMID:37600608 More...
|
|
NCBI chrNW_004955415:20,490,414...20,526,068
Ensembl chrNW_004955415:20,490,414...20,527,917
|
|
G |
Lamp5 |
lysosomal associated membrane protein family member 5 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:19,488,533...19,502,599
Ensembl chrNW_004955415:19,488,527...19,502,640
|
|
G |
Mkks |
MKKS centrosomal shuttling protein |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:20,292,311...20,315,850
Ensembl chrNW_004955415:20,292,663...20,300,797
|
|
G |
Pak5 |
p21 (RAC1) activated kinase 5 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:19,509,727...19,826,087
Ensembl chrNW_004955415:19,511,822...19,619,663
|
|
G |
Plcb1 |
phospholipase C beta 1 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:18,210,608...18,915,099
Ensembl chrNW_004955415:18,210,662...18,915,158
|
|
G |
Plcb4 |
phospholipase C beta 4 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:19,108,120...19,462,084
Ensembl chrNW_004955415:19,310,917...19,463,098
|
|
G |
Slx4ip |
SLX4 interacting protein |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:20,316,664...20,478,786
Ensembl chrNW_004955415:20,394,192...20,481,249
|
|
G |
Snap25 |
synaptosome associated protein 25 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:20,133,361...20,218,840
Ensembl chrNW_004955415:20,133,201...20,219,023
|
|
G |
Tmx4 |
thioredoxin related transmembrane protein 4 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome due to a JAG1 point mutation |
ClinVar |
PMID:10213047 PMID:11180599 PMID:16575836 PMID:19058200 PMID:22382802 PMID:24684524 PMID:28492532 PMID:32733715 More...
|
|
NCBI chrNW_004955415:18,055,257...18,100,705
Ensembl chrNW_004955415:18,054,323...18,101,446
|
|
|
G |
Notch2 |
notch receptor 2 |
|
ISO |
ClinVar Annotator: match by term: Alagille syndrome 2 |
OMIM ClinVar |
PMID:16773578 PMID:21378985 PMID:23389697 PMID:24728327 PMID:25016221 PMID:25741868 PMID:26627824 PMID:28492532 PMID:28512196 PMID:28566479 PMID:28776642 PMID:28941602 PMID:29698804 PMID:30143558 PMID:31749841 PMID:32164334 PMID:32368696 More...
|
|
NCBI chrNW_004955568:1,660,357...1,812,285
Ensembl chrNW_004955568:1,660,731...1,809,173
|
|
|
G |
Vipas39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis with renal dysfunction and cholestasis syndrome |
ClinVar |
PMID:20190753 PMID:25741868 |
|
NCBI chrNW_004955438:1,320,862...1,351,344
Ensembl chrNW_004955438:1,321,845...1,347,535
|
|
G |
Vps33b |
VPS33B late endosome and lysosome associated |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis with renal dysfunction and cholestasis syndrome |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955416:15,049,849...15,071,108
Ensembl chrNW_004955416:15,048,106...15,071,102
|
|
|
G |
Fbn1 |
fibrillin 1 |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955409:5,281,603...5,502,547
Ensembl chrNW_004955409:5,281,603...5,504,761
|
|
G |
Vipas39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
ClinVar |
PMID:25741868 PMID:31319225 |
|
NCBI chrNW_004955438:1,320,862...1,351,344
Ensembl chrNW_004955438:1,321,845...1,347,535
|
|
G |
Vps33b |
VPS33B late endosome and lysosome associated |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 1 |
OMIM ClinVar |
PMID:8151641 PMID:9536098 PMID:11668108 PMID:15052268 PMID:16896922 PMID:17576681 PMID:17994566 PMID:18853461 PMID:19274792 PMID:21851503 PMID:22753090 PMID:24782640 PMID:24917129 PMID:25741868 PMID:26505894 PMID:28492532 PMID:29907094 PMID:31343487 PMID:31479177 More...
|
|
NCBI chrNW_004955416:15,049,849...15,071,108
Ensembl chrNW_004955416:15,048,106...15,071,102
|
|
|
G |
Vipas39 |
VPS33B interacting protein, apical-basolateral polarity regulator, spe-39 homolog |
|
ISO |
ClinVar Annotator: match by term: Arthrogryposis, renal dysfunction, and cholestasis 2 |
OMIM ClinVar |
PMID:20190753 PMID:25741868 PMID:28492532 PMID:31479177 |
|
NCBI chrNW_004955438:1,320,862...1,351,344
Ensembl chrNW_004955438:1,321,845...1,347,535
|
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
|
ISO |
ClinVar Annotator: match by term: Summerskill syndrome |
OMIM ClinVar |
PMID:5807632 PMID:7894490 PMID:9500542 PMID:9918928 PMID:11815775 PMID:14988830 PMID:15239083 PMID:15317749 PMID:15657619 PMID:15888793 PMID:15975683 PMID:16199547 PMID:17592371 PMID:19260995 PMID:19731236 PMID:19918981 PMID:20232290 PMID:20414253 PMID:20981092 PMID:22525741 PMID:22995991 PMID:24033266 PMID:24260417 PMID:25421123 PMID:25737299 PMID:25741868 PMID:26126923 PMID:26382629 PMID:26678486 PMID:26858187 PMID:26879107 PMID:27050426 PMID:27530795 PMID:28492532 PMID:28733223 PMID:28924228 PMID:29238877 PMID:30366773 PMID:31450232 PMID:32650689 PMID:32695736 PMID:32942997 PMID:33437900 PMID:33666275 PMID:34016879 PMID:35416773 PMID:35431768 PMID:35894240 More...
|
|
NCBI chrNW_004955402:41,994,993...42,113,380
Ensembl chrNW_004955402:41,996,001...42,113,895
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
|
ISO |
ClinVar Annotator: match by term: Benign recurrent intrahepatic cholestasis type 2 |
OMIM ClinVar |
PMID:9536098 PMID:9806540 PMID:10579978 PMID:12370274 PMID:12717091 PMID:14672610 PMID:15300568 PMID:15317749 PMID:15791618 PMID:16039748 PMID:16199547 PMID:16290310 PMID:16641580 PMID:16868810 PMID:16871584 PMID:17241866 PMID:17576681 PMID:17855769 PMID:17947449 PMID:18395098 PMID:18692205 PMID:18798335 PMID:19101985 PMID:19750581 PMID:19845854 PMID:20232290 PMID:20414253 PMID:20583290 PMID:20683201 PMID:21404481 PMID:21490445 PMID:22364601 PMID:22609309 PMID:22795478 PMID:23022423 PMID:23279303 PMID:23437912 PMID:23750872 PMID:24115678 PMID:24231640 PMID:24339557 PMID:24402531 PMID:24530123 PMID:24627769 PMID:24711118 PMID:24969679 PMID:24991443 PMID:25716872 PMID:25741868 PMID:25771912 PMID:25847299 PMID:26019043 PMID:26126923 PMID:26382629 PMID:26678486 PMID:26858187 PMID:27050426 PMID:27114171 PMID:27153395 PMID:27239116 PMID:27368585 PMID:27426735 PMID:28027573 PMID:28119944 PMID:28425419 PMID:28454995 PMID:28492532 PMID:28733223 PMID:28776642 PMID:29104077 PMID:29316097 PMID:29404523 PMID:29412511 PMID:29625052 PMID:29992621 PMID:30210030 PMID:30366773 PMID:31015375 PMID:31091858 PMID:31450232 PMID:31538484 PMID:31745229 PMID:32087350 PMID:32309332 PMID:32581362 PMID:32793533 PMID:32808743 PMID:32860008 PMID:32917322 PMID:32942997 PMID:33201677 PMID:33215027 PMID:33915153 PMID:34008892 PMID:34016879 PMID:34942279 PMID:35257483 PMID:35780807 PMID:37471416 More...
|
|
NCBI chrNW_004955449:5,412,958...5,511,629
Ensembl chrNW_004955449:5,412,876...5,512,701
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24131658 |
RGD:151361287 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:25704541 |
RGD:11521169 |
NCBI chrNW_004955494:2,567,238...2,712,708
|
|
|
G |
Apob |
apolipoprotein B |
susceptibility |
ISO |
DNA:polymorphisms:intron, exon:IVS6+360C>T, 56C>T (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004955469:3,437,422...3,478,408
Ensembl chrNW_004955469:3,436,450...3,478,424
|
|
G |
Apoe |
apolipoprotein E |
susceptibility |
ISO |
DNA:SNP:intron:rs440446 (human) |
RGD |
PMID:18296645 |
RGD:2317550 |
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
|
|
G |
Atm |
ATM serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:9887333 PMID:17124347 PMID:20077034 PMID:25741868 PMID:26635394 PMID:28492532 More...
|
|
NCBI chrNW_004955412:10,422,753...10,531,406
Ensembl chrNW_004955412:10,426,135...10,530,545
|
|
G |
Mlh1 |
mutL homolog 1 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:15340264 PMID:17510385 PMID:18307539 PMID:19419416 PMID:22136435 PMID:22703879 PMID:24033266 PMID:24728327 PMID:25157968 PMID:25741868 PMID:25823662 PMID:28492532 More...
|
|
NCBI chrNW_004955421:3,890,291...3,936,892
Ensembl chrNW_004955421:3,890,306...3,936,526
|
|
G |
Msh2 |
mutS homolog 2 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:33357406 |
|
NCBI chrNW_004955441:14,188,315...14,247,608
Ensembl chrNW_004955441:14,187,805...14,247,698
|
|
G |
Palb2 |
partner and localizer of BRCA2 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 PMID:30287823 |
|
NCBI chrNW_004955493:2,149,053...2,175,482
Ensembl chrNW_004955493:2,147,862...2,175,781
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:12007219 PMID:16430766 PMID:17574468 PMID:25741868 PMID:26467025 PMID:27782177 More...
|
|
NCBI chrNW_004955442:15,132,555...15,178,377
Ensembl chrNW_004955442:15,145,640...15,178,377
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004955559:712,375...730,551
Ensembl chrNW_004955559:712,321...725,661
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
ISO |
ClinVar Annotator: match by term: Bile duct cancer |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955495:6,678,195...6,699,408
Ensembl chrNW_004955495:6,678,195...6,699,058
|
|
G |
Tjp1 |
tight junction protein 1 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19184677 |
RGD:2325030 |
NCBI chrNW_004955416:28,640,807...28,869,717
Ensembl chrNW_004955416:28,654,905...28,870,555
|
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
|
G |
Asph |
aspartate beta-hydroxylase |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:16673309 |
RGD:2325824 |
NCBI chrNW_004955444:17,116,060...17,320,966
Ensembl chrNW_004955444:17,121,559...17,318,295
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17341899 |
|
NCBI chrNW_004955456:321,222...456,431
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:17419223 |
RGD:2317786 |
NCBI chrNW_004955460:10,402,855...10,412,459
Ensembl chrNW_004955460:10,402,855...10,412,710
|
|
G |
Il6 |
interleukin 6 |
disease_progression |
ISO |
protein:increased expression:serum |
RGD |
PMID:17617204 |
RGD:2317166 |
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
|
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15892172 |
RGD:2317585 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
severity |
ISO |
protein:decreased expression:carcinoma of extrahepatic bile duct (human) |
RGD |
PMID:11986189 |
RGD:2317662 |
NCBI chrNW_004955477:7,103,035...7,375,073
Ensembl chrNW_004955477:7,102,977...7,376,530
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:9869516 |
RGD:2317706 |
NCBI chrNW_004955477:5,847,288...5,875,970
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
protein:increased expression:serum,bile |
RGD |
PMID:1657243 |
RGD:2325134 |
NCBI chrNW_004955563:432,160...581,330
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:16857800 |
RGD:2324929 |
NCBI chrNW_004955420:12,228,801...12,274,840
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
disease_progression |
ISO |
|
RGD |
PMID:8501910 PMID:9851639 |
RGD:2326076 RGD:2326077 |
NCBI chrNW_004955412:14,630,109...14,923,847
Ensembl chrNW_004955412:14,630,443...14,923,926
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
DNA:hypermethylation:promoter |
RGD |
PMID:15471559 |
RGD:2324957 |
NCBI chrNW_004955452:4,580,444...4,606,820
Ensembl chrNW_004955452:4,579,331...4,636,884
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21356120 |
RGD:5686894 |
NCBI chrNW_004955420:20,911,181...20,922,992
Ensembl chrNW_004955420:20,912,348...20,914,402
|
|
G |
Cd14 |
CD14 molecule |
disease_progression |
ISO |
mRNA, protein:increased expression:liver, plasma: |
RGD |
PMID:21172039 |
RGD:7184431 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:24493287 |
RGD:26884361 |
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Dlk1 |
delta like non-canonical Notch ligand 1 |
|
ISO |
|
RGD |
PMID:14743499 |
RGD:1625622 |
NCBI chrNW_004955627:37,886...43,730
Ensembl chrNW_004955627:38,128...43,728
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
disease_progression |
ISO |
|
RGD |
PMID:29056230 |
RGD:14701039 |
NCBI chrNW_004955455:8,082,578...8,099,523
|
|
G |
Gli2 |
GLI family zinc finger 2 |
disease_progression |
ISO |
|
RGD |
PMID:25746691 |
RGD:12802349 |
NCBI chrNW_004955459:8,892,917...9,124,672
Ensembl chrNW_004955459:8,892,869...9,118,499
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16627878 |
|
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
susceptibility |
ISO |
DNA:missense mutation:cds:p.G241R (human) |
RGD |
PMID:18401716 |
RGD:14402043 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Il18 |
interleukin 18 |
susceptibility |
ISO |
DNA:SNPs, haplotype:promoter:rs187238,rs1946518(human) protein:increased expression:serum: |
RGD |
PMID:10726686 PMID:30059753 |
RGD:14695528 RGD:14695529 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
mRNA:decreased expression:liver (human) |
RGD |
PMID:25487473 |
RGD:12832754 |
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
|
|
G |
Shh |
sonic hedgehog signaling molecule |
disease_progression |
ISO |
|
RGD |
PMID:25746691 |
RGD:12802349 |
NCBI chrNW_004955491:8,647,133...8,657,381
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
|
ISO |
|
MouseDO |
|
|
NCBI chrNW_004955454:13,689,403...13,690,019
|
|
G |
Spint1 |
serine peptidase inhibitor, Kunitz type 1 |
disease_progression |
ISO |
mRNA,protein:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chrNW_004955416:7,715,536...7,728,759
Ensembl chrNW_004955416:7,715,536...7,729,158
|
|
G |
Spint2 |
serine peptidase inhibitor, Kunitz type 2 |
|
ISO |
mRNA,protein:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chrNW_004955468:1,142,718...1,181,210
Ensembl chrNW_004955468:1,143,118...1,169,632
|
|
G |
Spp1 |
secreted phosphoprotein 1 |
|
ISO |
|
RGD |
PMID:15845635 |
RGD:1581370 |
NCBI chrNW_004955474:1,914,477...1,922,025
Ensembl chrNW_004955474:1,913,829...1,922,016
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
treatment |
ISO |
|
RGD |
PMID:30686515 |
RGD:14985228 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
|
G |
Angpt2 |
angiopoietin 2 |
|
ISO |
protein:increased expression:bile duct (rat) |
RGD |
PMID:16628643 |
RGD:2314213 |
NCBI chrNW_004955403:54,139,823...54,193,740
Ensembl chrNW_004955403:54,139,823...54,195,032
|
|
G |
Ift56 |
intraflagellar transport 56 |
|
ISO |
ClinVar Annotator: match by term: Caroli disease |
ClinVar |
PMID:25741868 PMID:31595528 PMID:32617964 |
|
NCBI chrNW_004955494:3,861,679...3,905,499
Ensembl chrNW_004955494:3,861,519...3,905,399
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
ClinVar Annotator: match by term: Caroli disease |
ClinVar |
PMID:1189128 PMID:11898128 PMID:12846734 PMID:12874454 PMID:15108277 PMID:15108281 PMID:15698423 PMID:15805161 PMID:16133180 PMID:19914852 PMID:20413436 PMID:21228398 PMID:25701400 PMID:25741868 PMID:26695994 PMID:27151922 PMID:27225849 PMID:27894351 PMID:28492530 PMID:28492532 PMID:29068549 PMID:30343465 PMID:30773290 PMID:31130284 PMID:31844813 PMID:31980526 PMID:32359821 PMID:32398770 PMID:32571524 PMID:32574212 PMID:32799815 PMID:35715958 More...
|
|
NCBI chrNW_004955411:5,988,100...6,434,369
Ensembl chrNW_004955411:5,990,316...6,432,301
|
|
G |
Wdr19 |
WD repeat domain 19 |
|
ISO |
associated with Nephronophthisis 13;DNA:missense mutations:cds:multiple (human) |
RGD |
PMID:25726036 |
RGD:11528287 |
NCBI chrNW_004955443:8,053,847...8,122,918
Ensembl chrNW_004955443:8,053,847...8,123,110
|
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
|
MouseDO |
|
|
NCBI chrNW_004955411:5,988,100...6,434,369
Ensembl chrNW_004955411:5,990,316...6,432,301
|
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
susceptibility |
ISO |
DNA:polymorphism:exon:c.3972C>T (human) |
RGD |
PMID:19451719 |
RGD:2317508 |
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
|
ISO |
protein:decreased expression:liver |
RGD |
PMID:16292515 |
RGD:2325640 |
NCBI chrNW_004955415:5,515,157...5,517,198
Ensembl chrNW_004955415:5,515,697...5,516,980
|
|
G |
Alb |
albumin |
disease_progression |
ISO |
|
RGD |
PMID:10776430 PMID:17545000 PMID:20431764 |
RGD:2325679 RGD:2325680 RGD:2325682 |
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
protein:increased expression:bile duct |
RGD |
PMID:18507031 |
RGD:2317521 |
NCBI chrNW_004955546:2,495,226...2,550,909
Ensembl chrNW_004955546:2,494,819...2,550,909
|
|
G |
Anxa2 |
annexin A2 |
disease_progression |
ISO |
|
RGD |
PMID:20493868 |
RGD:2325728 |
NCBI chrNW_004955450:14,545,586...14,574,161
Ensembl chrNW_004955450:14,512,381...14,574,696
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
DNA:loss of heterozygosity DNA:hypermethylation:promoter |
RGD |
PMID:10212000 PMID:15467712 |
RGD:2317198 RGD:2317205 |
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:19486127 |
RGD:2325756 |
NCBI chrNW_004955412:18,170,331...18,172,298
Ensembl chrNW_004955412:18,170,331...18,172,298
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
|
|
G |
Asph |
aspartate beta-hydroxylase |
|
ISO |
|
RGD |
PMID:21898484 |
RGD:6902945 |
NCBI chrNW_004955444:17,116,060...17,320,966
Ensembl chrNW_004955444:17,121,559...17,318,295
|
|
G |
Atg101 |
autophagy related 101 |
disease_progression |
ISO |
|
RGD |
PMID:35592424 |
RGD:153350091 |
NCBI chrNW_004955547:2,436,974...2,446,849
Ensembl chrNW_004955547:2,436,895...2,446,849
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 PMID:25231345 |
|
NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645
|
|
G |
Birc6 |
baculoviral IAP repeat containing 6 |
ameliorates |
ISO |
mRNA:increased expression:bile duct (human) |
RGD |
PMID:31964418 |
RGD:153344516 |
NCBI chrNW_004955441:740,299...923,920
Ensembl chrNW_004955441:739,567...922,959
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:12692057 |
RGD:11073239 |
NCBI chrNW_004955494:2,567,238...2,712,708
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Cxcr1 |
C-X-C motif chemokine receptor 1 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955453:15,181,027...15,196,224
Ensembl chrNW_004955453:15,194,205...15,195,272
|
|
G |
Egf |
epidermal growth factor |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955496:325,954...401,430
Ensembl chrNW_004955496:328,075...401,569
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 PMID:24728327 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955456:321,222...456,431
|
|
G |
Epo |
erythropoietin |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004955573:203,875...206,078
Ensembl chrNW_004955573:203,441...206,355
|
|
G |
Epor |
erythropoietin receptor |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:23052842 |
RGD:10400912 |
NCBI chrNW_004955495:2,293,587...2,299,302
Ensembl chrNW_004955495:2,293,540...2,298,715
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 |
|
NCBI chrNW_004955451:14,442,816...14,456,009
Ensembl chrNW_004955451:14,442,816...14,459,379
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
no_association disease_progression |
ISO |
DNA:SNPs: :g.148525904C>G, (rs2302427), g.148519011C>T (rs6464926), g.148517456T>G (rs17171119) (human) DNA:SNP: :g.148505302C>T (rs887569) (human) |
RGD |
PMID:24179546 |
RGD:126779604 |
NCBI chrNW_004955491:4,215,353...4,292,229
Ensembl chrNW_004955491:4,215,298...4,292,235
|
|
G |
Faslg |
Fas ligand |
|
ISO |
|
RGD |
PMID:11029528 |
RGD:2317746 |
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
|
ISO |
protein:increased expression:bile |
RGD |
PMID:11478488 |
RGD:2317765 |
NCBI chrNW_004955428:17,840,554...17,894,779
Ensembl chrNW_004955428:17,840,628...17,894,773
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004955551:2,321,190...2,427,000
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
disease_progression |
ISO |
protein:increased expression:bile ducts |
RGD |
PMID:19721413 |
RGD:2317780 |
NCBI chrNW_004955460:10,402,855...10,412,459
Ensembl chrNW_004955460:10,402,855...10,412,710
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
treatment |
ISO |
human cell line in a mouse model DNA:hypermethylation:promoter |
RGD |
PMID:12805482 PMID:15467712 |
RGD:14401711 RGD:2317198 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Hdac6 |
histone deacetylase 6 |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:23370327 |
RGD:9681560 |
NCBI chrNW_004955543:348,314...378,391
Ensembl chrNW_004955543:348,019...378,071
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
mRNA, protein:increased expression: : protein:increased expression:serum |
RGD |
PMID:10827151 PMID:16974053 |
RGD:2317909 RGD:2317925 |
NCBI chrNW_004955410:4,114,280...4,181,953
Ensembl chrNW_004955410:4,114,778...4,182,058
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:12919954 PMID:18550579 PMID:22647679 PMID:24120591 PMID:25741868 |
|
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il19 |
interleukin 19 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:11121048 PMID:14657422 PMID:14657427 PMID:18550579 PMID:25741868 PMID:28492532 More...
|
|
NCBI chrNW_004955406:42,376,102...42,384,902
Ensembl chrNW_004955406:42,376,104...42,384,902
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il1r2 |
interleukin 1 receptor type 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955470:7,518,565...7,562,219
Ensembl chrNW_004955470:7,518,663...7,559,470
|
|
G |
Il4r |
interleukin 4 receptor |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:18798553 |
RGD:2317263 |
NCBI chrNW_004955493:5,546,340...5,580,745
Ensembl chrNW_004955493:5,545,944...5,582,422
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:9769329 PMID:10720087 PMID:11001912 PMID:11889177 PMID:12519862 PMID:12560873 PMID:12719374 PMID:15070960 PMID:15331795 PMID:15472205 PMID:16150725 PMID:16278864 PMID:17623760 PMID:18550579 More...
|
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Ins |
insulin |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955422:13,909,408...13,910,419
Ensembl chrNW_004955422:13,909,407...13,910,419
|
|
G |
Kcnd2 |
potassium voltage-gated channel subfamily D member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34418280 |
|
NCBI chrNW_004955479:2,062,607...2,545,576
Ensembl chrNW_004955479:2,062,608...2,543,125
|
|
G |
Kit |
KIT proto-oncogene, receptor tyrosine kinase |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955447:16,149,014...16,226,151
Ensembl chrNW_004955447:16,148,605...16,226,734
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955491:6,245,408...6,420,535
Ensembl chrNW_004955491:6,247,249...6,402,470
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8968066 PMID:22561520 |
|
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
|
|
G |
Krt7 |
keratin 7 |
|
ISO |
|
RGD |
PMID:18393293 |
RGD:2317308 |
NCBI chrNW_004955547:2,584,425...2,598,770
Ensembl chrNW_004955547:2,533,377...2,598,833
|
|
G |
LOC102013768 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial |
|
ISO |
protein:increased expression:intrahepatic bile, extrahepatic bile duct (human) |
RGD |
PMID:23375797 |
RGD:151361187 |
NCBI chrNW_004955445:4,874,583...4,891,723
Ensembl chrNW_004955445:4,873,942...4,891,780
|
|
G |
LOC102023786 |
cytochrome c, somatic |
|
ISO |
|
RGD |
PMID:19788692 |
RGD:2317615 |
NCBI chrNW_004955410:27,086,405...27,089,255
Ensembl chrNW_004955410:27,086,405...27,089,255
|
|
G |
Mdm2 |
MDM2 proto-oncogene |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:15619210 |
RGD:2317417 |
NCBI chrNW_004955458:15,264,028...15,287,290
Ensembl chrNW_004955458:15,263,739...15,286,808
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
disease_progression |
ISO |
protein:increased phosphorylation:liver, carcinoma (human) protein:increased expression:liver, biliary epithelium (rat) |
RGD |
PMID:14656942 PMID:16818635 |
RGD:2317578 RGD:2317601 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
Mfsd4a |
major facilitator superfamily domain containing 4A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955406:41,286,679...41,315,666
Ensembl chrNW_004955406:41,286,679...41,322,158
|
|
G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
ISO |
DNA:hypermethylation:promoter (human) |
RGD |
PMID:17550320 |
RGD:2317632 |
NCBI chrNW_004955477:7,103,035...7,375,073
Ensembl chrNW_004955477:7,102,977...7,376,530
|
|
G |
Mki67 |
marker of proliferation Ki-67 |
disease_progression |
ISO |
|
RGD |
PMID:12903495 |
RGD:2317705 |
NCBI chrNW_004955477:5,847,288...5,875,970
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:15213623 PMID:19629755 |
RGD:2324667 RGD:2325769 |
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
mRNA:increased expression:bile duct protein:increased expression:bile duct |
RGD |
PMID:15213623 PMID:16463672 |
RGD:2324667 RGD:2325856 |
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
susceptibility |
ISO |
DNA:polymorphism (human) |
RGD |
PMID:17201138 |
RGD:2317119 |
NCBI chrNW_004955486:2,096,379...2,112,240
Ensembl chrNW_004955486:2,096,379...2,112,240
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO |
protein:increased secretion:bile mRNA:increased expression:bile duct protein:increased expression:bile duct: protein:increased expression:serum |
RGD |
PMID:15213623 PMID:18081149 PMID:19055478 PMID:19260467 PMID:19639217 |
RGD:2317986 RGD:2324622 RGD:2324638 RGD:2324664 RGD:2324667 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Muc16 |
mucin 16, cell surface associated |
|
ISO |
associated with Opisthorchiasis;protein:increased expression:serum |
RGD |
PMID:1653472 |
RGD:2325142 |
NCBI chrNW_004955563:432,160...581,330
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004955476:11,108,826...11,135,697
Ensembl chrNW_004955476:11,108,826...11,135,697
|
|
G |
Muc3a |
mucin 3A, cell surface associated |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004955573:45,920...60,091
|
|
G |
Muc4 |
mucin 4, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:14752841 PMID:19082442 |
RGD:2303602 RGD:2324944 |
NCBI chrNW_004955420:12,228,801...12,274,840
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
disease_progression |
ISO |
protein:increased expression:serum mRNA:increased expression:bile duct |
RGD |
PMID:11680592 PMID:14508831 |
RGD:2324948 RGD:2324990 |
NCBI chrNW_004955476:11,061,405...11,084,294
|
|
G |
Muc5b |
mucin 5B, oligomeric mucus/gel-forming |
|
ISO |
mRNA:decreased expression:bile duct |
RGD |
PMID:11680592 |
RGD:2324948 |
NCBI chrNW_004955476:11,021,665...11,049,239
|
|
G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
ISO |
protein:increased expression: : |
RGD |
PMID:10209489 |
RGD:2325167 |
NCBI chrNW_004955476:11,165,423...11,184,674
|
|
G |
Ncam1 |
neural cell adhesion molecule 1 |
|
ISO |
associated with hepatitis |
RGD |
PMID:12031086 |
RGD:2326079 |
NCBI chrNW_004955412:14,630,109...14,923,847
Ensembl chrNW_004955412:14,630,443...14,923,926
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:bile duct CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16094703 PMID:16818635 |
RGD:2325280 |
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
Notch1 |
notch receptor 1 |
|
ISO |
protein:increased expression:cholangiocyte |
RGD |
PMID:15887117 |
RGD:2325330 |
NCBI chrNW_004955513:4,225,939...4,264,875
Ensembl chrNW_004955513:4,225,956...4,263,259
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
disease_progression |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:24255171 |
RGD:15090822 |
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
disease_progression |
ISO |
DNA:loss of heterozygosity (human) |
RGD |
PMID:11260864 PMID:11866974 |
RGD:2317134 RGD:2317136 |
NCBI chrNW_004955561:1,277,362...1,282,949
Ensembl chrNW_004955561:1,277,365...1,282,793
|
|
G |
Osbp2 |
oxysterol binding protein 2 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004955455:4,928,153...5,110,178
Ensembl chrNW_004955455:4,928,207...5,110,999
|
|
G |
Osbpl7 |
oxysterol binding protein like 7 |
|
ISO |
mRNA:increased expression:blood |
RGD |
PMID:21763455 |
RGD:41404644 |
NCBI chrNW_004955451:13,289,938...13,301,243
Ensembl chrNW_004955451:13,291,577...13,300,322
|
|
G |
Panx2 |
pannexin 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955413:33,220,145...33,224,241
Ensembl chrNW_004955413:33,220,140...33,224,344
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
|
ISO |
mRNA,protein:decreased expression:cholangiocyte: |
RGD |
PMID:20724592 |
RGD:9835357 |
NCBI chrNW_004955405:18,434,711...18,540,710
Ensembl chrNW_004955405:18,434,711...18,540,710
|
|
G |
Pbrm1 |
polybromo 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24185509 |
|
NCBI chrNW_004955430:2,536,086...2,671,094
Ensembl chrNW_004955430:2,536,086...2,670,617
|
|
G |
Peg3 |
paternally expressed 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955567:85,913...96,236
|
|
G |
Pes1 |
pescadillo ribosomal biogenesis factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:34845814 |
|
NCBI chrNW_004955455:4,794,189...4,808,235
Ensembl chrNW_004955455:4,792,182...4,808,258
|
|
G |
Pir |
pirin |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955519:2,698,207...2,813,201
Ensembl chrNW_004955519:2,698,172...2,813,206
|
|
G |
Ppia |
peptidylprolyl isomerase A |
ameliorates |
ISO |
human cell line and construct in a mouse model |
RGD |
PMID:21871105 |
RGD:150429623 |
NCBI chrNW_004955456:7,381,923...7,383,203
|
|
G |
Ppp3ca |
protein phosphatase 3 catalytic subunit alpha |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955496:6,934,542...7,059,745
Ensembl chrNW_004955496:6,908,224...7,059,816
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
sexual_dimorphism |
ISO |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:28000796 |
RGD:151665188 |
NCBI chrNW_004955444:11,154,318...11,414,680
Ensembl chrNW_004955444:11,154,318...11,414,075
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004955415:32,794,172...32,807,944
Ensembl chrNW_004955415:32,793,718...32,812,930
|
|
G |
Prkacb |
protein kinase cAMP-activated catalytic subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26258846 |
|
NCBI chrNW_004955423:9,630,308...9,747,820
Ensembl chrNW_004955423:9,629,378...9,747,820
|
|
G |
Prrg4 |
proline rich and Gla domain 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955422:13,305,422...13,327,188
Ensembl chrNW_004955422:13,305,549...13,326,964
|
|
G |
Prss56 |
serine protease 56 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955453:3,440,871...3,446,090
Ensembl chrNW_004955453:3,441,109...3,446,090
|
|
G |
Pten |
phosphatase and tensin homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23376645 PMID:27022031 |
RGD:12802341 |
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
|
|
NCBI chrNW_004955406:25,077,988...25,086,259
Ensembl chrNW_004955406:25,079,945...25,086,171
|
|
G |
Rassf8 |
Ras association domain family member 8 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955413:21,029,725...21,052,837
Ensembl chrNW_004955413:20,929,095...21,053,087
|
|
G |
Rnf39 |
ring finger protein 39 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955583:201,638...206,754
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
CTD Direct Evidence: marker/mechanism associated with opisthorchiasis;DNA:SNPs:multiple: (human) |
CTD RGD |
PMID:22561520 |
RGD:151361227 |
NCBI chrNW_004955451:4,604,985...4,680,762
Ensembl chrNW_004955451:4,604,985...4,680,762
|
|
G |
Robo2 |
roundabout guidance receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955407:14,301,689...15,549,561
Ensembl chrNW_004955407:14,305,498...14,842,790
|
|
G |
Runx3 |
RUNX family transcription factor 3 |
|
ISO |
protein:decreased expression:bile duct |
RGD |
PMID:19827872 |
RGD:2324955 |
NCBI chrNW_004955452:4,580,444...4,606,820
Ensembl chrNW_004955452:4,579,331...4,636,884
|
|
G |
Slc4a4 |
solute carrier family 4 member 4 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955447:1,599,986...1,900,791
Ensembl chrNW_004955447:1,599,929...1,900,791
|
|
G |
Slc5a5 |
solute carrier family 5 member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17408651 |
|
NCBI chrNW_004955524:3,372,539...3,380,758
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression treatment |
ISO |
|
RGD |
PMID:24131658 PMID:25475870 PMID:28347255 |
RGD:151361214 RGD:151361287 RGD:151361294 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
G |
Smad4 |
SMAD family member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22561520 |
|
NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
severity |
ISO |
protein:decreased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004955506:4,222,455...4,225,563
Ensembl chrNW_004955506:4,222,455...4,225,563
|
|
G |
Sox17 |
SRY-box transcription factor 17 |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004955454:13,689,403...13,690,019
|
|
G |
Sox2 |
SRY-box transcription factor 2 |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955420:10,671,888...10,674,080
Ensembl chrNW_004955420:10,671,978...10,672,934
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
disease_progression |
ISO |
protein:increased expression:pancreas |
RGD |
PMID:12632524 PMID:16083599 |
RGD:1299231 RGD:2325020 |
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Tgfbr2 |
transforming growth factor beta receptor 2 |
|
ISO |
mRNA:increased expression:bile duct |
RGD |
PMID:12632524 |
RGD:1299231 |
NCBI chrNW_004955430:21,919,338...21,999,688
Ensembl chrNW_004955430:21,932,553...22,001,837
|
|
G |
Thbs1 |
thrombospondin 1 |
disease_progression |
ISO |
DNA:hypermethylation (human) |
RGD |
PMID:11927969 PMID:12213730 PMID:16465407 |
RGD:2325024 RGD:2325026 RGD:2325027 |
NCBI chrNW_004955416:6,490,034...6,506,419
Ensembl chrNW_004955416:6,489,451...6,506,419
|
|
G |
Tnc |
tenascin C |
severity |
ISO |
|
RGD |
PMID:20816680 |
RGD:4889598 |
NCBI chrNW_004955419:12,569,620...12,662,897
Ensembl chrNW_004955419:12,569,547...12,662,958
|
|
G |
Tnfaip3 |
TNF alpha induced protein 3 |
severity |
ISO |
protein:increased expression:bile duct (human) |
RGD |
PMID:26485275 |
RGD:11250478 |
NCBI chrNW_004955436:21,566,591...21,581,551
Ensembl chrNW_004955436:21,566,423...21,578,469
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16818635 PMID:22561520 |
|
NCBI chrNW_004955467:9,241,391...9,256,716
Ensembl chrNW_004955467:9,252,130...9,255,928
|
|
G |
Ttr |
transthyretin |
|
ISO |
protein:decreased expression:blood serum (human) |
RGD |
PMID:18275060 |
RGD:151660506 |
NCBI chrNW_004955402:18,921,235...18,927,976
Ensembl chrNW_004955402:18,921,274...18,928,108
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
ClinVar Annotator: match by term: Cholangiocarcinoma |
ClinVar |
PMID:18550579 |
|
NCBI chrNW_004955437:9,527,445...9,541,908
|
|
G |
Wdhd1 |
WD repeat and HMG-box DNA binding protein 1 |
ameliorates |
ISO |
|
RGD |
PMID:30314946 |
RGD:156420141 |
NCBI chrNW_004955409:8,539,617...8,587,537
|
|
G |
Wnt9a |
Wnt family member 9A |
disease_progression |
ISO |
mRNA:altered expression:liver (human) |
RGD |
PMID:31687280 |
RGD:152998978 |
NCBI chrNW_004955581:422,028...438,321
Ensembl chrNW_004955581:421,451...438,380
|
|
|
G |
Cd40lg |
CD40 ligand |
treatment |
ISO |
|
RGD |
PMID:23820408 |
RGD:11352285 |
NCBI chrNW_004955489:8,465,571...8,477,714
Ensembl chrNW_004955489:8,465,164...8,477,746
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
|
ISO |
|
RGD |
PMID:22576464 |
RGD:10401932 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
severity |
ISO |
associated with intrahepatic cholangiocarcinoma; DNA:missense mutations:cds:p. R132C, R132G, and R132L (human) |
RGD |
PMID:31121195 |
RGD:14974230 |
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
|
|
|
G |
Ca2 |
carbonic anhydrase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15816485 |
|
NCBI chrNW_004955417:3,388,110...3,402,798
Ensembl chrNW_004955417:3,386,087...3,402,363
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007
|
|
G |
Itgb6 |
integrin subunit beta 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chrNW_004955449:13,387,013...13,520,879
Ensembl chrNW_004955449:13,448,084...13,520,879
|
|
G |
Nras |
NRAS proto-oncogene, GTPase |
|
ISO |
mRNA:increased expression:cd4-positive helper T cells (human) |
RGD |
PMID:30690835 |
RGD:14975104 |
NCBI chrNW_004955435:18,001,517...18,009,105
Ensembl chrNW_004955435:18,001,517...18,009,103
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
|
RGD |
PMID:29158418 |
RGD:14700923 |
NCBI chrNW_004955411:5,988,100...6,434,369
Ensembl chrNW_004955411:5,990,316...6,432,301
|
|
G |
Tgfb2 |
transforming growth factor beta 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chrNW_004955406:174,949...249,248
Ensembl chrNW_004955406:172,814...249,248
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25055964 |
|
NCBI chrNW_004955516:507,113...511,360
Ensembl chrNW_004955516:505,789...512,118
|
|
G |
Tlr2 |
toll like receptor 2 |
disease_progression |
ISO |
|
RGD |
PMID:30340822 |
RGD:15090860 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
mRNA,protein:decreased expression:liver |
RGD |
PMID:28146070 |
RGD:14401745 |
NCBI chrNW_004955500:6,745,725...6,798,052
Ensembl chrNW_004955500:6,745,678...6,798,048
|
|
|
G |
Pot1 |
protection of telomeres 1 |
|
ISO |
mRNA:decreased expression:gall bladder |
RGD |
PMID:28643740 |
RGD:151356941 |
NCBI chrNW_004955479:6,140,599...6,230,512
Ensembl chrNW_004955479:6,140,501...6,209,031
|
|
|
G |
Aqp1 |
aquaporin 1 (Colton blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chrNW_004955410:32,066,196...32,078,661
Ensembl chrNW_004955410:32,066,196...32,078,717
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chrNW_004955432:23,179,645...23,328,347
Ensembl chrNW_004955432:23,178,866...23,328,382
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
DNA:deletion:exon: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:15830394 PMID:18988797 |
RGD:14700991 |
NCBI chrNW_004955411:5,988,100...6,434,369
Ensembl chrNW_004955411:5,990,316...6,432,301
|
|
G |
Sct |
secretin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chrNW_004955476:11,433,857...11,434,662
Ensembl chrNW_004955476:11,433,969...11,434,574
|
|
G |
Slc4a2 |
solute carrier family 4 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18988797 |
|
NCBI chrNW_004955491:5,498,472...5,513,389
Ensembl chrNW_004955491:5,499,033...5,517,319
|
|
|
G |
Aspg |
asparaginase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12902918 |
|
NCBI chrNW_004955538:2,765,215...2,785,390
Ensembl chrNW_004955538:2,765,104...2,785,526
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
susceptibility treatment |
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver mRNA:altered expression:liver (rat) |
CTD RGD |
PMID:11179459 PMID:12702498 PMID:22461449 PMID:24713091 PMID:27090119 PMID:27593105 PMID:29087027 More...
|
RGD:14402412 RGD:14402414 RGD:15090804 RGD:1598571 |
NCBI chrNW_004955449:5,412,958...5,511,629
Ensembl chrNW_004955449:5,412,876...5,512,701
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
treatment disease_progression |
ISO |
CTD Direct Evidence: marker/mechanism mRNA:altered expression:liver (rat) mRNA,protein:decreased expression:intestine: |
CTD RGD |
PMID:10869290 PMID:12702498 PMID:15057744 PMID:16037978 PMID:17009103 PMID:17681005 PMID:22521610 PMID:27090119 More...
|
RGD:11081007 RGD:11081011 RGD:15090804 RGD:1598571 RGD:1598614 |
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
|
|
G |
Abcc3 |
ATP binding cassette subfamily C member 3 |
|
ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:18096675 PMID:22461449 PMID:23486593 |
RGD:11535162 RGD:2301060 |
NCBI chrNW_004955451:11,087,246...11,130,108
Ensembl chrNW_004955451:11,087,570...11,130,482
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
treatment |
ISO |
protein:altered expression:kidney, liver |
RGD |
PMID:15030973 PMID:30223280 |
RGD:15045612 RGD:2301085 |
NCBI chrNW_004955404:14,700,808...14,927,944
Ensembl chrNW_004955404:14,700,808...14,928,617
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
|
ISO |
|
RGD |
PMID:16764892 |
RGD:1598662 |
NCBI chrNW_004955441:10,964,588...10,987,771
Ensembl chrNW_004955441:10,964,858...10,986,967
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
|
ISO |
|
RGD |
PMID:16764892 |
RGD:1598662 |
NCBI chrNW_004955441:10,982,307...11,004,789
Ensembl chrNW_004955441:10,982,307...11,009,116
|
|
G |
Adamts13 |
ADAM metallopeptidase with thrombospondin type 1 motif 13 |
|
ISO |
mRNA, protein:increased expression, increased activity:liver, plasma (rat) |
RGD |
PMID:19652891 |
RGD:2315953 |
NCBI chrNW_004955513:2,761,386...2,786,447
Ensembl chrNW_004955513:2,764,186...2,786,187
|
|
G |
Agt |
angiotensinogen |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
|
|
G |
Alb |
albumin |
|
ISO |
|
RGD |
PMID:6431134 |
RGD:11035297 |
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Aldh1b1 |
aldehyde dehydrogenase 1 family member B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955419:28,155,174...28,159,752
Ensembl chrNW_004955419:28,155,174...28,159,752
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family member L1 |
treatment |
ISO |
|
RGD |
PMID:30223280 |
RGD:15045612 |
NCBI chrNW_004955421:21,420,264...21,506,004
Ensembl chrNW_004955421:21,420,147...21,527,037
|
|
G |
Aldh8a1 |
aldehyde dehydrogenase 8 family member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955439:1,773,884...1,794,325
Ensembl chrNW_004955439:1,773,861...1,794,328
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
|
RGD |
PMID:17201892 |
RGD:10054045 |
NCBI chrNW_004955412:18,165,667...18,168,015
Ensembl chrNW_004955412:18,165,667...18,168,015
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
associated with Pancreatic Neoplasms;protein:increased expression:plasma |
RGD |
PMID:19055369 |
RGD:2317548 |
NCBI chrNW_004955555:1,998,170...2,002,003
Ensembl chrNW_004955555:1,999,711...2,001,888
|
|
G |
Arg1 |
arginase 1 |
|
ISO |
protein:altered activity:liver (rat) |
RGD |
PMID:15916970 |
RGD:4143230 |
NCBI chrNW_004955436:12,235,767...12,247,817
Ensembl chrNW_004955436:12,235,767...12,251,972
|
|
G |
Bcat1 |
branched chain amino acid transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955413:19,975,395...20,087,656
Ensembl chrNW_004955413:19,981,328...20,087,638
|
|
G |
Blvra |
biliverdin reductase A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18706437 |
|
NCBI chrNW_004955460:129,077...167,345
Ensembl chrNW_004955460:125,854...167,506
|
|
G |
Bmal1 |
basic helix-loop-helix ARNT like 1 |
|
ISO |
mRNA:increased expression:cholangiocyte |
RGD |
PMID:21757639 |
RGD:10043349 |
NCBI chrNW_004955414:28,652,663...28,748,360
Ensembl chrNW_004955414:28,684,226...28,748,360
|
|
G |
Btg3 |
BTG anti-proliferation factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955407:18,927,211...18,939,576
Ensembl chrNW_004955407:18,927,211...18,941,424
|
|
G |
Cadps2 |
calcium dependent secretion activator 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955479:3,961,877...4,485,710
Ensembl chrNW_004955479:3,961,731...4,485,710
|
|
G |
Cat |
catalase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:21339256 PMID:27989131 |
RGD:5130873 |
NCBI chrNW_004955422:11,783,973...11,826,970
Ensembl chrNW_004955422:11,781,835...11,827,464
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
|
RGD |
PMID:22511970 |
RGD:7183752 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
Cd44 |
CD44 molecule (IN blood group) |
|
ISO |
protein:decreased expression:jejunum, ileum |
RGD |
PMID:16804311 |
RGD:2289372 |
NCBI chrNW_004955422:11,106,061...11,189,951
|
|
G |
Cftr |
CF transmembrane conductance regulator |
|
ISO |
mRNA,Protein:increased expression |
RGD |
PMID:15605366 |
RGD:1599598 |
NCBI chrNW_004955432:23,179,645...23,328,347
Ensembl chrNW_004955432:23,178,866...23,328,382
|
|
G |
Clock |
clock circadian regulator |
|
ISO |
mRNA:increased expression:cholangiocyte |
RGD |
PMID:21757639 |
RGD:10043349 |
NCBI chrNW_004955447:15,394,496...15,537,969
Ensembl chrNW_004955447:15,454,630...15,530,906
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26884397 |
|
NCBI chrNW_004955411:15,052,151...15,077,320
Ensembl chrNW_004955411:15,052,163...15,077,320
|
|
G |
Cnr2 |
cannabinoid receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26884397 |
|
NCBI chrNW_004955452:3,763,742...3,795,069
Ensembl chrNW_004955452:3,763,742...3,795,069
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
treatment |
ISO |
mRNA:increased expression:liver (mouse) mRNA:increased expression:liver (rat) |
RGD |
PMID:21274875 PMID:22094456 PMID:22824087 |
RGD:8552675 RGD:8552699 RGD:8552776 |
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
|
|
G |
Cp |
ceruloplasmin |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:29523470 |
RGD:14401716 |
NCBI chrNW_004955448:470,063...522,909
Ensembl chrNW_004955448:473,179...523,100
|
|
G |
CUNH4orf19 |
chromosome unknown C4orf19 homolog |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955443:9,540,047...9,628,483
Ensembl chrNW_004955443:9,540,825...9,565,119
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
associated with Chronic Hepatitis C; protein:increased expression:serum: |
RGD |
PMID:30507970 |
RGD:27095896 |
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955414:16,059,781...16,089,727
Ensembl chrNW_004955414:16,059,781...16,089,727
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955410:12,814,993...12,820,852
Ensembl chrNW_004955410:12,814,479...12,822,777
|
|
G |
Dnajc12 |
DnaJ heat shock protein family (Hsp40) member C12 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955425:20,202,264...20,236,416
Ensembl chrNW_004955425:20,200,239...20,236,408
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007
|
|
G |
Eng |
endoglin |
|
ISO |
protein:increased expression:liver (rat) |
RGD |
PMID:21146604 |
RGD:7257529 |
NCBI chrNW_004955419:818,797...853,319
Ensembl chrNW_004955419:818,932...852,694
|
|
G |
Erlec1 |
endoplasmic reticulum lectin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955441:19,535,425...19,557,960
Ensembl chrNW_004955441:19,535,425...19,557,458
|
|
G |
F2rl3 |
F2R like thrombin or trypsin receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chrNW_004955524:1,045,493...1,047,924
Ensembl chrNW_004955524:1,044,792...1,047,819
|
|
G |
Fga |
fibrinogen alpha chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20974703 |
|
NCBI chrNW_004955471:8,806,964...8,814,671
Ensembl chrNW_004955471:8,806,650...8,816,791
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO |
|
RGD |
PMID:18802767 |
RGD:2307352 |
NCBI chrNW_004955580:1,045,294...1,058,129
Ensembl chrNW_004955580:1,045,294...1,057,083
|
|
G |
Ghr |
growth hormone receptor |
|
ISO |
mRNA,protein:decreased expression:liver, skeletal muscle: |
RGD |
PMID:15604202 |
RGD:11567216 |
NCBI chrNW_004955426:26,553,509...26,873,619
Ensembl chrNW_004955426:26,689,581...26,871,684
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
treatment |
ISO |
|
RGD |
PMID:23960717 |
RGD:10401941 |
NCBI chrNW_004955422:17,914,228...17,916,918
Ensembl chrNW_004955422:17,914,305...17,917,428
|
|
G |
Gtpbp2 |
GTP binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955437:9,414,128...9,425,671
Ensembl chrNW_004955437:9,412,934...9,424,365
|
|
G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955430:2,055,774...2,096,260
Ensembl chrNW_004955430:2,053,640...2,096,432
|
|
G |
Hao2 |
hydroxyacid oxidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955435:22,380,395...22,404,426
Ensembl chrNW_004955435:22,380,388...22,404,052
|
|
G |
Hjv |
hemojuvelin BMP co-receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955568:80,386...84,707
Ensembl chrNW_004955568:80,444...84,834
|
|
G |
Hoga1 |
4-hydroxy-2-oxoglutarate aldolase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955507:3,687,449...3,711,939
Ensembl chrNW_004955507:3,687,769...3,711,151
|
|
G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25526675 |
|
NCBI chrNW_004955493:7,835,160...7,838,428
Ensembl chrNW_004955493:7,835,160...7,838,428
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Id1 |
inhibitor of DNA binding 1, HLH protein |
|
ISO |
protein:increased expression:liver, nucleus (rat) |
RGD |
PMID:16628634 |
RGD:9686088 |
NCBI chrNW_004955422:29,337,969...29,339,178
Ensembl chrNW_004955422:29,337,757...29,339,178
|
|
G |
Id4 |
inhibitor of DNA binding 4, HLH protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955483:6,598,804...6,601,496
Ensembl chrNW_004955483:6,600,867...6,602,564
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD RGD |
PMID:12826230 PMID:18607346 |
RGD:10046052 |
NCBI chrNW_004955405:37,505,830...37,582,152
Ensembl chrNW_004955405:37,512,201...37,582,152
|
|
G |
Il1a |
interleukin 1 alpha |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:19535096 |
RGD:2311076 |
NCBI chrNW_004955470:1,527,710...1,538,418
Ensembl chrNW_004955470:1,527,674...1,538,466
|
|
G |
Il2 |
interleukin 2 |
treatment |
ISO |
|
RGD |
PMID:29698570 |
RGD:14928214 |
NCBI chrNW_004955428:18,163,010...18,168,157
Ensembl chrNW_004955428:18,162,467...18,168,265
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
|
RGD |
PMID:20031157 |
RGD:2317270 |
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461449 |
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Invs |
inversin |
|
ISO |
|
RGD |
PMID:10421642 |
RGD:155791685 |
NCBI chrNW_004955419:25,445,404...25,584,244
Ensembl chrNW_004955419:25,444,582...25,581,201
|
|
G |
Kank1 |
KN motif and ankyrin repeat domains 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955434:5,247,278...5,279,043
Ensembl chrNW_004955434:5,191,846...5,279,739
|
|
G |
Kmt2b |
lysine methyltransferase 2B |
|
ISO |
mRNA:decreased expression:liver (mouse) |
RGD |
PMID:21330447 |
RGD:9588602 |
NCBI chrNW_004955468:2,813,183...2,834,326
Ensembl chrNW_004955468:2,813,496...2,834,326
|
|
G |
Lamp2 |
lysosomal associated membrane protein 2 |
|
ISO |
in hemizygote mutant male (LAMP2y/-) |
RGD |
PMID:28124283 |
RGD:13703118 |
NCBI chrNW_004955572:1,423,048...1,464,443
Ensembl chrNW_004955572:1,422,981...1,462,622
|
|
G |
LOC102004889 |
sterol 26-hydroxylase, mitochondrial |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15795599 |
|
NCBI chrNW_004955453:14,601,495...14,647,383
Ensembl chrNW_004955453:14,601,444...14,647,366
|
|
G |
LOC102008593 |
cholesterol 7-alpha-monooxygenase |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:9797378 PMID:22461449 PMID:29655695 |
RGD:15090803 |
NCBI chrNW_004955454:17,035,105...17,078,854
Ensembl chrNW_004955454:17,036,204...17,042,756
|
|
G |
LOC102010322 |
cytochrome P450 1A2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27565560 |
|
NCBI chrNW_004955450:3,165,107...3,171,894
Ensembl chrNW_004955450:3,165,106...3,171,942
|
|
G |
LOC102019604 |
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22461449 |
|
NCBI chrNW_004955420:27,988,067...27,990,637
|
|
G |
LOC102021597 |
alpha-1-antiproteinase S-like |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:4117022 |
|
NCBI chrNW_004955438:17,920,200...17,929,105
|
|
G |
LOC102022645 |
25-hydroxycholesterol 7-alpha-hydroxylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9802883 |
|
NCBI chrNW_004955444:14,274,818...14,446,068
Ensembl chrNW_004955444:14,275,345...14,444,426
|
|
G |
Ly96 |
lymphocyte antigen 96 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955444:6,356,121...6,387,350
Ensembl chrNW_004955444:6,356,154...6,387,529
|
|
G |
Maob |
monoamine oxidase B |
|
ISO |
protein:altered activity:hypothalamus (rat) |
RGD |
PMID:18802767 |
RGD:2307352 |
NCBI chrNW_004955516:4,328,286...4,473,419
Ensembl chrNW_004955516:4,328,476...4,472,593
|
|
G |
Mapk13 |
mitogen-activated protein kinase 13 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chrNW_004955437:3,899,988...3,907,781
Ensembl chrNW_004955437:3,899,950...3,909,114
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chrNW_004955437:3,836,331...3,884,083
Ensembl chrNW_004955437:3,838,232...3,884,083
|
|
G |
Mboat1 |
membrane bound O-acyltransferase domain containing 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955483:6,273,729...6,379,844
Ensembl chrNW_004955483:6,273,729...6,381,559
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
treatment |
ISO |
|
RGD |
PMID:21274875 |
RGD:8552699 |
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20977460 |
|
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Nfxl1 |
nuclear transcription factor, X-box binding like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955443:665,235...714,627
Ensembl chrNW_004955443:668,031...713,481
|
|
G |
Niban1 |
niban apoptosis regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955406:23,437,430...23,523,307
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12612912 PMID:20626112 |
|
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
protein:decreased activity:liver (rat) |
RGD |
PMID:11352814 |
RGD:7775033 |
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
Nphp4 |
nephrocystin 4 |
|
ISO |
ClinVar Annotator: match by term: Cholestasis |
ClinVar |
PMID:15776426 PMID:22550138 PMID:25741868 PMID:28492532 PMID:28700940 |
|
NCBI chrNW_004955486:6,442,058...6,547,451
Ensembl chrNW_004955486:6,448,442...6,547,488
|
|
G |
Npl |
N-acetylneuraminate pyruvate lyase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955406:21,633,979...21,670,279
Ensembl chrNW_004955406:21,633,032...21,670,958
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:22461449 PMID:28337145 |
RGD:13439750 |
NCBI chrNW_004955484:7,012,373...7,028,182
Ensembl chrNW_004955484:7,012,506...7,027,604
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1 group D member 1 |
|
ISO |
|
RGD |
PMID:24497272 |
RGD:10448995 |
NCBI chrNW_004955451:14,743,763...14,750,903
Ensembl chrNW_004955451:14,742,735...14,750,999
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1 group H member 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17256725 |
|
NCBI chrNW_004955559:731,630...736,973
Ensembl chrNW_004955559:730,670...737,505
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1 group H member 3 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:17256725 |
|
NCBI chrNW_004955422:940,310...954,170
Ensembl chrNW_004955422:940,310...949,049
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
severity treatment |
ISO |
mutant FXR-/- mouse CTD Direct Evidence: marker/mechanism mRNA:increased expression:ileum (rat) mRNA:altered expression:liver (rat) mRNA, protein:altered expression:liver (rat) |
RGD CTD |
PMID:12949728 PMID:22461449 PMID:23178280 PMID:27090119 PMID:29235094 PMID:30061734 PMID:30077711 PMID:30223280 More...
|
RGD:14701031 RGD:15042872 RGD:15045597 RGD:15045612 RGD:15090804 RGD:15092071 |
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1 group I member 2 |
disease_progression |
ISO |
|
RGD |
PMID:29204052 |
RGD:13782189 |
NCBI chrNW_004955427:19,459,936...19,487,276
Ensembl chrNW_004955427:19,459,936...19,487,276
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1 group I member 3 |
disease_progression |
ISO |
|
RGD |
PMID:29204052 |
RGD:13782189 |
NCBI chrNW_004955468:12,985,105...13,002,850
|
|
G |
Otc |
ornithine transcarbamylase |
|
ISO |
protein:decreased activity:liver (rat) |
RGD |
PMID:15916970 |
RGD:4143230 |
NCBI chrNW_004955601:481,524...543,176
Ensembl chrNW_004955601:481,480...543,176
|
|
G |
Pan2 |
poly(A) specific ribonuclease subunit PAN2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955458:3,925,356...3,946,879
Ensembl chrNW_004955458:3,926,070...3,941,506
|
|
G |
Pdgfb |
platelet derived growth factor subunit B |
|
ISO |
mRNA,protein:increased expression:cholangiocyte, bible duct: |
RGD |
PMID:10424289 |
RGD:10449495 |
NCBI chrNW_004955413:25,150,702...25,166,987
Ensembl chrNW_004955413:25,148,062...25,166,987
|
|
G |
Pdyn |
prodynorphin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16919318 |
|
NCBI chrNW_004955415:13,106,087...13,119,497
Ensembl chrNW_004955415:13,106,062...13,119,515
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:3421781 |
|
NCBI chrNW_004955469:7,217,233...7,220,401
Ensembl chrNW_004955469:7,217,363...7,220,386
|
|
G |
Pon1 |
paraoxonase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955432:11,893,473...11,923,035
Ensembl chrNW_004955432:11,893,473...11,923,339
|
|
G |
Prkaa1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
treatment |
ISO |
mRNA:altered expression:liver (rat) |
RGD |
PMID:27090119 |
RGD:15090804 |
NCBI chrNW_004955426:25,079,718...25,102,090
Ensembl chrNW_004955426:25,079,718...25,102,090
|
|
G |
Pygm |
glycogen phosphorylase, muscle associated |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:11804660 |
RGD:1599990 |
NCBI chrNW_004955422:20,411,480...20,424,676
Ensembl chrNW_004955422:20,411,480...20,424,931
|
|
G |
Rdx |
radixin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17681005 |
|
NCBI chrNW_004955412:12,100,436...12,184,444
Ensembl chrNW_004955412:12,100,359...12,172,545
|
|
G |
Reep5 |
receptor accessory protein 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955418:2,504,028...2,539,574
Ensembl chrNW_004955418:2,502,674...2,536,817
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chrNW_004955422:19,602,930...19,612,263
Ensembl chrNW_004955422:19,603,345...19,611,516
|
|
G |
Rflnb |
refilin B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955481:2,102,576...2,107,947
Ensembl chrNW_004955481:2,102,586...2,107,967
|
|
G |
Serpina5 |
serpin family A member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955438:17,787,398...17,796,013
Ensembl chrNW_004955438:17,787,399...17,796,414
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chrNW_004955456:16,147,523...16,157,040
Ensembl chrNW_004955456:16,145,944...16,157,142
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
treatment |
ISO |
mRNA:altered expression:liver (rat) |
RGD |
PMID:27090119 PMID:29655695 |
RGD:15090803 RGD:15090804 |
NCBI chrNW_004955466:597,081...609,254
Ensembl chrNW_004955466:597,204...608,756
|
|
G |
Slc10a7 |
solute carrier family 10 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955428:1,999,341...2,250,201
Ensembl chrNW_004955428:1,999,280...2,250,234
|
|
G |
Slc16a2 |
solute carrier family 16 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955562:305,850...455,764
Ensembl chrNW_004955562:306,051...458,889
|
|
G |
Slc23a1 |
solute carrier family 23 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18706437 |
|
NCBI chrNW_004955418:1,176,390...1,192,270
Ensembl chrNW_004955418:1,176,000...1,186,940
|
|
G |
Slc23a2 |
solute carrier family 23 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18706437 |
|
NCBI chrNW_004955415:15,565,344...15,677,935
Ensembl chrNW_004955415:15,565,249...15,642,153
|
|
G |
Slc30a10 |
solute carrier family 30 member 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955520:3,631,192...3,641,595
|
|
G |
Slc51a |
solute carrier family 51 member A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16423920 PMID:22461449 |
|
NCBI chrNW_004955420:12,452,562...12,463,369
Ensembl chrNW_004955420:12,453,554...12,463,150
|
|
G |
Slc51b |
SLC51 subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16423920 PMID:22461449 |
|
NCBI chrNW_004955450:10,365,554...10,374,209
Ensembl chrNW_004955450:10,365,554...10,374,209
|
|
G |
Slco1a2 |
solute carrier organic anion transporter family member 1A2 |
treatment |
ISO |
mRNA:altered expression:liver (rat) |
RGD |
PMID:27090119 |
RGD:15090804 |
NCBI chrNW_004955413:16,821,808...16,910,511
Ensembl chrNW_004955413:16,821,791...16,912,903
|
|
G |
Snai1 |
snail family transcriptional repressor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chrNW_004955445:8,232,084...8,237,893
Ensembl chrNW_004955445:8,231,924...8,237,996
|
|
G |
Sorl1 |
sortilin related receptor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955412:22,421,984...22,576,179
Ensembl chrNW_004955412:22,421,984...22,576,179
|
|
G |
Sort1 |
sortilin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28453831 |
|
NCBI chrNW_004955435:12,725,952...12,819,280
Ensembl chrNW_004955435:12,730,270...12,819,029
|
|
G |
Spint1 |
serine peptidase inhibitor, Kunitz type 1 |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chrNW_004955416:7,715,536...7,728,759
Ensembl chrNW_004955416:7,715,536...7,729,158
|
|
G |
Spint2 |
serine peptidase inhibitor, Kunitz type 2 |
|
ISO |
mRNA:increased expression:liver: |
RGD |
PMID:21898507 |
RGD:10043111 |
NCBI chrNW_004955468:1,142,718...1,181,210
Ensembl chrNW_004955468:1,143,118...1,169,632
|
|
G |
Srp72 |
signal recognition particle 72 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955447:14,519,978...14,552,758
Ensembl chrNW_004955447:14,519,064...14,552,758
|
|
G |
Sult2b1 |
sulfotransferase family 2B member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27052460 |
|
NCBI chrNW_004955559:1,942,878...1,968,895
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
|
RGD |
PMID:8707259 |
RGD:2290364 |
NCBI chrNW_004955516:507,113...511,360
Ensembl chrNW_004955516:505,789...512,118
|
|
G |
Tjp1 |
tight junction protein 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:18197414 |
RGD:2325141 |
NCBI chrNW_004955416:28,640,807...28,869,717
Ensembl chrNW_004955416:28,654,905...28,870,555
|
|
G |
Tlr2 |
toll like receptor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Tmem117 |
transmembrane protein 117 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955500:3,097,088...3,566,616
Ensembl chrNW_004955500:3,087,715...3,568,105
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20626112 |
|
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Uba5 |
ubiquitin like modifier activating enzyme 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26881866 |
|
NCBI chrNW_004955501:5,841,516...5,864,304
Ensembl chrNW_004955501:5,841,606...5,870,953
|
|
G |
Usp53 |
ubiquitin specific peptidase 53 |
|
ISO |
ClinVar Annotator: match by term: Cholestasis |
ClinVar |
PMID:25741868 PMID:28492532 PMID:32124521 PMID:32759993 PMID:34608165 |
|
NCBI chrNW_004955428:20,957,807...21,023,380
Ensembl chrNW_004955428:20,957,807...21,023,380
|
|
G |
Utp4 |
UTP4 small subunit processome component |
|
ISO |
North American Indian childhood cirrhosis, OMIM:604901, R565W |
RGD |
PMID:12417987 |
RGD:1600653 |
NCBI chrNW_004955484:7,501,784...7,531,757
Ensembl chrNW_004955484:7,500,613...7,531,198
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21224055 |
|
NCBI chrNW_004955435:5,390,745...5,410,025
Ensembl chrNW_004955435:5,390,751...5,411,691
|
|
G |
Vil1 |
villin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955453:14,935,450...14,961,011
Ensembl chrNW_004955453:14,935,456...14,961,011
|
|
G |
Vps33b |
VPS33B late endosome and lysosome associated |
|
ISO |
ARC syndrome, OMIM:208085 |
RGD |
PMID:15052268 |
RGD:1599749 |
NCBI chrNW_004955416:15,049,849...15,071,108
Ensembl chrNW_004955416:15,048,106...15,071,102
|
|
G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27989131 |
|
NCBI chrNW_004955478:4,309,975...4,341,107
Ensembl chrNW_004955478:4,309,880...4,343,934
|
|
|
G |
Ahi1 |
Abelson helper integration site 1 |
|
ISO |
ClinVar Annotator: match by term: Joubert syndrome with ocular defect |
ClinVar |
PMID:15322546 PMID:16453322 PMID:18054307 PMID:21623382 PMID:21937992 PMID:25525159 PMID:25741868 PMID:26092869 PMID:28442542 PMID:28492532 PMID:29186038 More...
|
|
NCBI chrNW_004955439:1,277,185...1,460,296
Ensembl chrNW_004955439:1,276,760...1,474,202
|
|
G |
Ofd1 |
OFD1 centriole and centriolar satellite protein |
|
ISO |
ClinVar Annotator: match by term: Joubert syndrome with congenital hepatic fibrosis |
ClinVar |
PMID:16783569 PMID:18546297 PMID:27081566 PMID:28492532 |
|
NCBI chrNW_004955519:4,433,747...4,470,842
Ensembl chrNW_004955519:4,433,855...4,471,070
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
ISO |
DNA:missense mutations: :multiple CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19058225 PMID:19574260 |
RGD:11535944 RGD:11535946 |
NCBI chrNW_004955417:10,097,488...10,137,959
Ensembl chrNW_004955417:10,097,472...10,138,644
|
|
|
G |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
|
ISO |
ClinVar Annotator: match by term: COACH syndrome 1 |
ClinVar |
PMID:18414213 PMID:18950740 PMID:19777577 PMID:21068128 PMID:22241855 PMID:22425360 PMID:23012439 PMID:24706459 PMID:25741868 PMID:26092869 PMID:26477546 PMID:26485645 PMID:26673778 PMID:26729329 PMID:27081510 PMID:27082236 PMID:28492532 PMID:28518168 PMID:29146704 PMID:29620724 PMID:32461654 More...
|
|
NCBI chrNW_004955480:8,404,239...8,514,792
Ensembl chrNW_004955480:8,400,284...8,514,736
|
|
G |
Rpgrip1l |
RPGRIP1 like |
|
ISO |
ClinVar Annotator: match by term: COACH syndrome 1 |
ClinVar |
PMID:17558407 PMID:17558409 PMID:19430481 PMID:21866095 PMID:25741868 PMID:26092869 PMID:28492532 PMID:28771248 PMID:31390572 More...
|
|
NCBI chrNW_004955433:11,321,504...11,423,981
Ensembl chrNW_004955433:11,322,590...11,424,569
|
|
G |
Tmem67 |
transmembrane protein 67 |
|
ISO |
ClinVar Annotator: match by term: COACH syndrome 1 |
OMIM ClinVar |
PMID:2929661 PMID:8862632 PMID:9375913 PMID:9536098 PMID:12368986 PMID:17160906 PMID:17377820 PMID:17397051 PMID:17576681 PMID:18327255 PMID:18414213 PMID:19058225 PMID:19466712 PMID:19508969 PMID:19540516 PMID:19574260 PMID:20232449 PMID:20607301 PMID:21068128 PMID:21633164 PMID:21866095 PMID:22700954 PMID:23351400 PMID:23559409 PMID:24033266 PMID:25326635 PMID:25412400 PMID:25741868 PMID:25920555 PMID:26035863 PMID:26092869 PMID:26467025 PMID:26729329 PMID:27434533 PMID:27491411 PMID:28125082 PMID:28492532 PMID:28497568 PMID:28680603 PMID:28719906 PMID:28771248 PMID:28973083 PMID:29127258 PMID:29146704 PMID:29568536 PMID:29891882 PMID:29974258 PMID:30029678 PMID:30476936 PMID:34675960 PMID:36617405 More...
|
|
NCBI chrNW_004955417:10,097,488...10,137,959
Ensembl chrNW_004955417:10,097,472...10,138,644
|
|
|
G |
Cc2d2a |
coiled-coil and C2 domain containing 2A |
|
ISO |
ClinVar Annotator: match by term: COACH syndrome 2 |
OMIM ClinVar |
PMID:18950740 PMID:19466712 PMID:19574260 PMID:19777577 PMID:22241855 PMID:22246503 PMID:25741868 PMID:26092869 PMID:28125082 PMID:28492532 PMID:32488064 More...
|
|
NCBI chrNW_004955480:8,404,239...8,514,792
Ensembl chrNW_004955480:8,400,284...8,514,736
|
|
|
G |
Rpgrip1l |
RPGRIP1 like |
|
ISO |
ClinVar Annotator: match by term: COACH syndrome 3 |
OMIM ClinVar |
PMID:9536098 PMID:17558407 PMID:17558409 PMID:17576681 PMID:17960139 PMID:18565097 PMID:19430481 PMID:19574260 PMID:21866095 PMID:25741868 PMID:26092869 PMID:27434533 PMID:28492532 PMID:28771248 PMID:31390572 More...
|
|
NCBI chrNW_004955433:11,321,504...11,423,981
Ensembl chrNW_004955433:11,322,590...11,424,569
|
|
|
G |
Apob |
apolipoprotein B |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:18076041 |
RGD:2325763 |
NCBI chrNW_004955469:3,437,422...3,478,408
Ensembl chrNW_004955469:3,436,450...3,478,424
|
|
G |
Fscn1 |
fascin actin-bundling protein 1 |
|
ISO |
mRNA, protein:increased expression: : |
RGD |
PMID:15136764 |
RGD:2317789 |
NCBI chrNW_004955460:10,402,855...10,412,459
Ensembl chrNW_004955460:10,402,855...10,412,710
|
|
G |
Mtap |
methylthioadenosine phosphorylase |
|
ISO |
DNA, protein:deletion, decreased expression:common bile duct: |
RGD |
PMID:15662124 |
RGD:2317954 |
NCBI chrNW_004955472:12,391,399...12,439,221
Ensembl chrNW_004955472:12,390,032...12,439,206
|
|
G |
Muc1 |
mucin 1, cell surface associated |
disease_progression |
ISO |
protein:increased expression:bile duct |
RGD |
PMID:8766528 |
RGD:2324856 |
NCBI chrNW_004955545:1,657,728...1,662,112
|
|
G |
Muc4 |
mucin 4, cell surface associated |
|
ISO |
protein:increased expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chrNW_004955420:12,228,801...12,274,840
|
|
G |
Muc5ac |
mucin 5AC, oligomeric mucus/gel-forming |
|
ISO |
protein:altered expression:pancreas |
RGD |
PMID:8143972 |
RGD:2324890 |
NCBI chrNW_004955476:11,061,405...11,084,294
|
|
G |
Tymp |
thymidine phosphorylase |
disease_progression |
ISO |
|
RGD |
PMID:10760693 |
RGD:2325158 |
NCBI chrNW_004955413:33,505,424...33,509,095
Ensembl chrNW_004955413:33,505,446...33,508,748
|
|
|
G |
Akr1d1 |
aldo-keto reductase family 1 member D1 |
|
ISO |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect |
ClinVar |
|
|
NCBI chrNW_004955494:4,799,706...4,856,100
Ensembl chrNW_004955494:4,799,450...4,854,696
|
|
G |
LOC102022645 |
25-hydroxycholesterol 7-alpha-hydroxylase |
|
ISO |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955444:14,274,818...14,446,068
Ensembl chrNW_004955444:14,275,345...14,444,426
|
|
|
G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
ISO |
ClinVar Annotator: match by term: 3-BETA-HYDROXY-DELTA-5-C27-STEROID OXIDOREDUCTASE DEFICIENCY | ClinVar Annotator: match by term: Congenital bile acid synthesis defect 1 | ClinVar Annotator: match by term: HSD3B7-related condition |
OMIM ClinVar |
PMID:3470305 PMID:11067870 PMID:12679481 PMID:25741868 PMID:26712441 PMID:28492532 PMID:34627351 More...
|
|
NCBI chrNW_004955493:7,835,160...7,838,428
Ensembl chrNW_004955493:7,835,160...7,838,428
|
|
|
G |
Akr1d1 |
aldo-keto reductase family 1 member D1 |
|
ISO |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 2 |
OMIM ClinVar |
PMID:8707100 PMID:12970144 PMID:15030995 PMID:16199547 PMID:18243262 PMID:19175828 PMID:20522910 PMID:21185810 PMID:23679950 PMID:25741868 PMID:28492532 PMID:30809085 PMID:31450232 PMID:37314652 PMID:38062451 More...
|
|
NCBI chrNW_004955494:4,799,706...4,856,100
Ensembl chrNW_004955494:4,799,450...4,854,696
|
|
|
G |
LOC102022645 |
25-hydroxycholesterol 7-alpha-hydroxylase |
|
ISO |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 3 |
OMIM ClinVar |
PMID:1943942 PMID:9802883 PMID:18252231 PMID:18367963 PMID:19363635 PMID:19439420 PMID:19812052 PMID:21541746 PMID:21567895 PMID:21623769 PMID:22384504 PMID:23812641 PMID:24117163 PMID:24641183 PMID:24927729 PMID:25741868 PMID:26467025 PMID:27077743 PMID:27217339 PMID:27879216 PMID:27957547 PMID:28039895 PMID:28492532 PMID:28832565 PMID:29228183 PMID:29980238 More...
|
|
NCBI chrNW_004955444:14,274,818...14,446,068
Ensembl chrNW_004955444:14,275,345...14,444,426
|
|
|
G |
Amacr |
alpha-methylacyl-CoA racemase |
|
ISO |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 4 |
OMIM ClinVar |
PMID:9584266 PMID:10655068 PMID:12512044 PMID:15249642 PMID:18032455 PMID:20818383 PMID:20821052 PMID:21576695 PMID:21686617 PMID:25741868 PMID:28492532 PMID:30369941 More...
|
|
NCBI chrNW_004955426:19,570,179...19,580,920
Ensembl chrNW_004955426:19,570,070...19,580,818
|
|
G |
Slc45a2 |
solute carrier family 45 member 2 |
|
ISO |
ClinVar Annotator: match by term: Congenital bile acid synthesis defect 4 |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955426:19,498,942...19,530,628
Ensembl chrNW_004955426:19,498,942...19,530,628
|
|
|
G |
Abcd3 |
ATP binding cassette subfamily D member 3 |
|
ISO |
ClinVar Annotator: match by term: ABCD3-related condition | ClinVar Annotator: match by term: Congenital bile acid synthesis defect 5 |
OMIM ClinVar |
PMID:25168382 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955423:280,497...359,711
Ensembl chrNW_004955423:280,497...359,711
|
|
|
G |
Acox2 |
acyl-CoA oxidase 2 |
|
ISO |
ClinVar Annotator: match by term: ACOX2-related condition | ClinVar Annotator: match by term: Congenital bile acid synthesis defect 6 |
OMIM ClinVar |
PMID:9536098 PMID:16199547 PMID:17576681 PMID:25741868 PMID:27647924 PMID:27884763 PMID:28492532 PMID:35395098 PMID:35775617 More...
|
|
NCBI chrNW_004955430:1,638,931...1,665,308
Ensembl chrNW_004955430:1,638,431...1,665,141
|
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645
|
|
G |
Pbrm1 |
polybromo 1 |
disease_progression |
ISO |
|
RGD |
PMID:25536104 |
RGD:150340631 |
NCBI chrNW_004955430:2,536,086...2,671,094
Ensembl chrNW_004955430:2,536,086...2,670,617
|
|
G |
Rac1 |
Rac family small GTPase 1 |
|
ISO |
protein:increased expression:mucosa (human) |
RGD |
PMID:21537609 |
RGD:153350126 |
NCBI chrNW_004955460:13,270,159...13,295,562
Ensembl chrNW_004955460:13,270,159...13,311,351
|
|
G |
Slc7a5 |
solute carrier family 7 member 5 |
disease_progression |
ISO |
|
RGD |
PMID:24890221 |
RGD:151361210 |
NCBI chrNW_004955541:2,103,437...2,129,668
Ensembl chrNW_004955541:2,103,384...2,130,310
|
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
|
ISO |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955442:15,132,555...15,178,377
Ensembl chrNW_004955442:15,145,640...15,178,377
|
|
G |
Pold1 |
DNA polymerase delta 1, catalytic subunit |
|
ISO |
ClinVar Annotator: match by term: Extrahepatic bile duct cancer |
ClinVar |
PMID:25741868 PMID:26467025 PMID:28492532 |
|
NCBI chrNW_004955559:712,375...730,551
Ensembl chrNW_004955559:712,321...725,661
|
|
G |
Xpo1 |
exportin 1 |
disease_progression |
ISO |
protein:increased expression:extrahepatic bile duct (human) |
RGD |
PMID:27279267 |
RGD:151665800 |
NCBI chrNW_004955424:22,370,006...22,420,568
Ensembl chrNW_004955424:22,370,006...22,420,568
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
|
ISO |
mRNA,protein:increased expression:liver, basolateral plasma membrane (rat) |
RGD |
PMID:28660384 |
RGD:21203516 |
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
|
|
G |
Abcc4 |
ATP binding cassette subfamily C member 4 (PEL blood group) |
treatment |
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:29360226 |
RGD:14995480 |
NCBI chrNW_004955404:14,700,808...14,927,944
Ensembl chrNW_004955404:14,700,808...14,928,617
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:31932644 |
|
NCBI chrNW_004955425:4,023,001...4,039,980
Ensembl chrNW_004955425:4,026,430...4,040,747
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955436:12,523,602...12,526,986
Ensembl chrNW_004955436:12,522,944...12,526,480
|
|
G |
Cd68 |
CD68 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955467:9,340,490...9,343,912
Ensembl chrNW_004955467:9,341,364...9,343,836
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:31932644 |
|
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
|
|
G |
Col3a1 |
collagen type III alpha 1 chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955403:9,720,831...9,758,019
Ensembl chrNW_004955403:9,721,114...9,757,887
|
|
G |
Crh |
corticotropin releasing hormone |
|
ISO |
protein:decreased expression:hypothalamus (rat) |
RGD |
PMID:8387536 |
RGD:5490980 |
NCBI chrNW_004955444:12,989,210...12,991,300
|
|
G |
Cygb |
cytoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955506:5,766,006...5,775,722
Ensembl chrNW_004955506:5,766,006...5,775,784
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955523:307,181...310,728
Ensembl chrNW_004955523:305,728...310,728
|
|
G |
Gjb1 |
gap junction protein beta 1 |
|
ISO |
mRNA,protein:decreased expression:liver: |
RGD |
PMID:7762611 |
RGD:7349397 |
NCBI chrNW_004955475:10,779,415...10,787,910
Ensembl chrNW_004955475:10,785,996...10,787,910
|
|
G |
Gjb2 |
gap junction protein beta 2 |
|
ISO |
|
RGD |
PMID:7762611 |
RGD:7349397 |
NCBI chrNW_004955497:987,213...989,477
Ensembl chrNW_004955497:988,422...989,099
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:19652645 |
RGD:11041639 |
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955431:15,373,207...15,377,339
Ensembl chrNW_004955431:15,373,207...15,377,339
|
|
G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 |
|
ISO |
mRNA, protein:decreased expression:liver, mitochondrion (rat) |
RGD |
PMID:12399220 |
RGD:2326121 |
NCBI chrNW_004955435:22,804,484...22,820,807
Ensembl chrNW_004955435:22,804,484...22,821,482
|
|
G |
Hnf1a |
HNF1 homeobox A |
|
ISO |
mRNA,protein,DNA:decreased expression, decreased binding, decreased expression:liver, nuclear (rat) |
RGD |
PMID:15723437 |
RGD:14700989 |
NCBI chrNW_004955455:10,694,102...10,717,613
Ensembl chrNW_004955455:10,694,102...10,717,613
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il6 |
interleukin 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955464:1,107,598...1,110,326
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955495:1,704,695...1,711,339
Ensembl chrNW_004955495:1,704,695...1,711,290
|
|
G |
Lgals1 |
galectin 1 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:18225978 |
RGD:2316551 |
NCBI chrNW_004955413:24,072,086...24,075,452
Ensembl chrNW_004955413:24,072,086...24,075,452
|
|
G |
LOC102004889 |
sterol 26-hydroxylase, mitochondrial |
treatment |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:29360226 |
RGD:14995480 |
NCBI chrNW_004955453:14,601,495...14,647,383
Ensembl chrNW_004955453:14,601,444...14,647,366
|
|
G |
LOC102008593 |
cholesterol 7-alpha-monooxygenase |
treatment |
ISO |
mRNA:decreased expression:liver, nucleus (rat) mRNA:decreased expression:liver (rat) |
RGD |
PMID:28660384 PMID:29360226 |
RGD:14995480 RGD:21203516 |
NCBI chrNW_004955454:17,035,105...17,078,854
Ensembl chrNW_004955454:17,036,204...17,042,756
|
|
G |
LOC102019604 |
7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase |
treatment |
ISO |
mRNA:decreased expression:liver (rat) |
RGD |
PMID:29360226 |
RGD:14995480 |
NCBI chrNW_004955420:27,988,067...27,990,637
|
|
G |
Map3k7 |
mitogen-activated protein kinase kinase kinase 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955411:17,177,335...17,229,957
Ensembl chrNW_004955411:17,177,335...17,229,957
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955442:17,284,232...17,380,026
Ensembl chrNW_004955442:17,284,232...17,380,020
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955437:3,836,331...3,884,083
Ensembl chrNW_004955437:3,838,232...3,884,083
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955493:6,870,699...6,876,836
Ensembl chrNW_004955493:6,869,668...6,879,152
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955556:1,593,552...1,705,543
Ensembl chrNW_004955556:1,593,494...1,665,784
|
|
G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955408:391,094...430,638
Ensembl chrNW_004955408:391,094...430,981
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Mpo |
myeloperoxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955451:4,743,744...4,753,358
Ensembl chrNW_004955451:4,743,744...4,753,358
|
|
G |
Myd88 |
MYD88 innate immune signal transduction adaptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955427:25,553,589...25,557,654
Ensembl chrNW_004955427:25,553,589...25,559,138
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:30026087 PMID:31900718 |
RGD:21201303 |
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955491:5,438,228...5,457,308
Ensembl chrNW_004955491:5,438,010...5,460,814
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
disease_progression treatment |
ISO |
protein:increased expression:liver (rat) mRNA:increased expression:liver (rat) human gene in mouse model |
RGD |
PMID:14623915 PMID:22057115 PMID:29138817 PMID:29360226 |
RGD:14928333 RGD:14995480 RGD:15042871 RGD:1625205 |
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
|
|
G |
Oprm1 |
opioid receptor mu 1 |
|
ISO |
mRNA:decreased expression:hypothalamus, hippocampus |
RGD |
PMID:25290008 |
RGD:401842371 |
NCBI chrNW_004955439:7,870,563...7,923,817
Ensembl chrNW_004955439:7,757,569...7,923,817
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
treatment |
ISO |
|
RGD |
PMID:18466260 |
RGD:10449503 |
NCBI chrNW_004955415:4,365,848...4,403,317
Ensembl chrNW_004955415:4,365,743...4,403,587
|
|
G |
Ptn |
pleiotrophin |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:18225978 |
RGD:2316551 |
NCBI chrNW_004955494:5,580,264...5,681,848
Ensembl chrNW_004955494:5,580,422...5,684,190
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:30026087 |
|
NCBI chrNW_004955422:19,602,930...19,612,263
Ensembl chrNW_004955422:19,603,345...19,611,516
|
|
G |
Setd7 |
SET domain containing 7, histone lysine methyltransferase |
treatment |
ISO |
|
RGD |
PMID:24097032 |
RGD:9491846 |
NCBI chrNW_004955428:4,131,431...4,178,250
Ensembl chrNW_004955428:4,131,103...4,178,250
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
protein:increased expression:kidney |
RGD |
PMID:20814153 |
RGD:7243879 |
NCBI chrNW_004955439:20,567,241...20,608,281
Ensembl chrNW_004955439:20,567,212...20,609,105
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 PMID:30026087 PMID:31932644 |
|
NCBI chrNW_004955555:274,405...288,441
Ensembl chrNW_004955555:270,652...288,441
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955516:507,113...511,360
Ensembl chrNW_004955516:505,789...512,118
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955506:3,769,113...3,812,896
Ensembl chrNW_004955506:3,768,646...3,813,820
|
|
G |
Tlr4 |
toll like receptor 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955419:10,190,937...10,201,896
Ensembl chrNW_004955419:10,191,120...10,202,135
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28789951 |
|
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
|
G |
Tjp2 |
tight junction protein 2 |
|
ISO |
ClinVar Annotator: match by term: Familial primary biliary cirrhosis |
ClinVar |
PMID:25741868 PMID:28492532 PMID:32439973 |
|
NCBI chrNW_004955434:3,781,368...3,923,240
Ensembl chrNW_004955434:3,781,113...3,923,391
|
|
|
G |
Ctsb |
cathepsin B |
|
ISO |
protein:decreased activity:liver (rat) |
RGD |
PMID:19696938 |
RGD:2315504 |
NCBI chrNW_004955403:53,086,236...53,100,217
Ensembl chrNW_004955403:53,085,574...53,093,809
|
|
G |
Glud1 |
glutamate dehydrogenase 1 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:10431747 |
RGD:6484593 |
NCBI chrNW_004955510:5,987,811...6,021,001
|
|
|
G |
LOC102007967 |
mitochondrial chaperone BCS1 |
|
ISO |
ClinVar Annotator: match by term: GRACILE syndrome |
OMIM ClinVar |
PMID:9545407 PMID:11528392 PMID:12215968 PMID:12547234 PMID:12910490 PMID:16199547 PMID:17314340 PMID:17403714 PMID:18386115 PMID:18771761 PMID:19162478 PMID:19285991 PMID:19389488 PMID:19508421 PMID:20518024 PMID:21274865 PMID:22277166 PMID:22310368 PMID:23892085 PMID:24033266 PMID:24172246 PMID:24236502 PMID:24655110 PMID:24704045 PMID:25741868 PMID:25895478 PMID:25914718 PMID:25954003 PMID:26467025 PMID:26489029 PMID:26563427 PMID:27618451 PMID:27959697 PMID:28105683 PMID:28128857 PMID:28322498 PMID:28427446 PMID:28490743 PMID:28492532 PMID:28496993 PMID:29090881 PMID:30582773 PMID:30634555 PMID:31435670 PMID:32313153 PMID:32552793 PMID:33511646 PMID:34645488 PMID:34662929 More...
|
|
NCBI chrNW_004955453:14,762,237...14,766,693
Ensembl chrNW_004955453:14,762,237...14,766,383
|
|
|
G |
Med12 |
mediator complex subunit 12 |
|
ISO |
ClinVar Annotator: match by term: Cholestasis-pigmentary retinopathy-cleft palate syndrome | ClinVar Annotator: match by term: Hardikar syndrome |
OMIM ClinVar |
PMID:9286458 PMID:20301719 PMID:24728327 PMID:25741868 PMID:28492532 PMID:30006928 PMID:32174975 PMID:33244165 PMID:33244166 PMID:33913598 PMID:34079076 More...
|
|
NCBI chrNW_004955475:10,687,168...10,710,286
Ensembl chrNW_004955475:10,687,367...10,710,053
|
|
|
G |
Ank1 |
ankyrin 1 |
severity |
ISO |
DNA:deletion mutation:exon: ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Dominant |
RGD ClinVar |
PMID:14671619 PMID:25741868 PMID:28492532 |
RGD:11251681 |
NCBI chrNW_004955536:1,049,325...1,237,943
Ensembl chrNW_004955536:1,049,407...1,237,943
|
|
G |
Cad |
carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38827 |
|
NCBI chrNW_004955469:9,203,433...9,227,526
Ensembl chrNW_004955469:9,203,434...9,227,865
|
|
G |
Dhodh |
dihydroorotate dehydrogenase (quinone) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38827 |
|
NCBI chrNW_004955484:4,699,743...4,713,466
Ensembl chrNW_004955484:4,699,722...4,713,466
|
|
G |
Epb42 |
erythrocyte membrane protein band 4.2 |
|
ISO |
ClinVar Annotator: match by term: Spherocytosis, Recessive |
ClinVar |
PMID:28492532 |
|
NCBI chrNW_004955416:9,784,211...9,800,453
Ensembl chrNW_004955416:9,784,260...9,798,194
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955468:3,980,999...4,007,553
Ensembl chrNW_004955468:3,980,999...4,008,652
|
|
G |
Klf1 |
KLF transcription factor 1 |
|
ISO |
DNA:missense mutation:exon:p.E339D (1065A>T) (human) |
RGD MouseDO |
PMID:20691777 |
RGD:10769342 |
NCBI chrNW_004955415:31,939,994...31,943,539
Ensembl chrNW_004955415:31,939,873...31,943,545
|
|
G |
Slc4a1 |
solute carrier family 4 member 1 (Diego blood group) |
|
ISO |
ClinVar Annotator: match by term: Spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Dominant |
ClinVar |
PMID:25741868 PMID:28492532 PMID:36231035 |
|
NCBI chrNW_004955451:17,318,600...17,330,943
Ensembl chrNW_004955451:17,315,024...17,328,103
|
|
G |
Spta1 |
spectrin alpha, erythrocytic 1 |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Dominant | ClinVar Annotator: match by term: Spherocytosis, Recessive ClinVar Annotator: match by term: Congenital spherocytosis | ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Recessive |
ClinVar |
PMID:8941647 PMID:15384986 PMID:24033266 PMID:25741868 PMID:27292444 PMID:28492532 PMID:30976395 PMID:31038472 PMID:31147440 PMID:31333484 PMID:31723846 More...
|
|
NCBI chrNW_004955468:10,472,601...10,545,402
Ensembl chrNW_004955468:10,472,671...10,545,313
|
|
G |
Sptb |
spectrin beta, erythrocytic |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis | ClinVar Annotator: match by term: Spherocytosis | ClinVar Annotator: match by term: Spherocytosis, Dominant |
ClinVar |
PMID:19538529 PMID:25741868 PMID:28492532 PMID:29396846 PMID:34201899 |
|
NCBI chrNW_004955466:5,013,963...5,170,186
Ensembl chrNW_004955466:5,097,116...5,167,596
|
|
G |
Umps |
uridine monophosphate synthetase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:38827 |
|
NCBI chrNW_004955427:23,825,529...23,841,427
Ensembl chrNW_004955427:23,825,523...23,841,152
|
|
|
G |
Add2 |
adducin 2 |
|
ISO |
OMIM:182900 |
MouseDO |
|
|
NCBI chrNW_004955424:14,411,279...14,517,813
Ensembl chrNW_004955424:14,411,124...14,517,813
|
|
G |
Ank1 |
ankyrin 1 |
|
ISO |
ClinVar Annotator: match by term: ANK1-related condition | ClinVar Annotator: match by term: Hereditary spherocytosis type 1 | ClinVar Annotator: match by term: Spherocytosis, type 1, autosomal recessive |
OMIM ClinVar |
PMID:1486040 PMID:7883994 PMID:8640229 PMID:9536098 PMID:9590147 PMID:9887280 PMID:11102985 PMID:11167760 PMID:11372755 PMID:11527968 PMID:12899723 PMID:15071790 PMID:16037067 PMID:16199547 PMID:17327413 PMID:17576681 PMID:21099109 PMID:24033266 PMID:25741868 PMID:27292444 PMID:27427187 PMID:28102861 PMID:28492532 PMID:29396846 PMID:29449435 PMID:29572776 PMID:29597199 PMID:30207817 PMID:31016877 PMID:31122244 PMID:31602632 PMID:31669644 PMID:31723846 PMID:31980736 PMID:32436265 PMID:32518793 PMID:32641076 PMID:32702754 PMID:33014018 PMID:33074480 PMID:33116287 PMID:33620149 PMID:33868383 PMID:34335240 PMID:34953813 PMID:36071563 PMID:36598564 PMID:36816036 PMID:38592584 More...
|
|
NCBI chrNW_004955536:1,049,325...1,237,943
Ensembl chrNW_004955536:1,049,407...1,237,943
|
|
G |
Epb42 |
erythrocyte membrane protein band 4.2 |
|
ISO |
OMIM:182900 |
MouseDO |
|
|
NCBI chrNW_004955416:9,784,211...9,800,453
Ensembl chrNW_004955416:9,784,260...9,798,194
|
|
G |
Spta1 |
spectrin alpha, erythrocytic 1 |
|
ISO |
OMIM:182900 |
MouseDO |
|
|
NCBI chrNW_004955468:10,472,601...10,545,402
Ensembl chrNW_004955468:10,472,671...10,545,313
|
|
|
G |
Plekhg3 |
pleckstrin homology and RhoGEF domain containing G3 |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis type 2 | ClinVar Annotator: match by term: SPTB-related condition |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004955466:5,172,603...5,212,518
Ensembl chrNW_004955466:5,173,213...5,188,381
|
|
G |
Sptb |
spectrin beta, erythrocytic |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis type 2 | ClinVar Annotator: match by term: SPTB-related condition |
OMIM ClinVar |
PMID:1391962 PMID:1498324 PMID:6426236 PMID:7883966 PMID:8018926 PMID:8667615 PMID:8844207 PMID:9536098 PMID:9714702 PMID:11703334 PMID:17576681 PMID:19538529 PMID:25741868 PMID:26830532 PMID:27292444 PMID:28102861 PMID:28492532 PMID:29572776 PMID:29758562 PMID:30198572 PMID:30486584 PMID:31122244 PMID:31126250 PMID:31602632 PMID:31807509 PMID:32436265 PMID:32641076 PMID:33074480 PMID:36135330 PMID:38592584 More...
|
|
NCBI chrNW_004955466:5,013,963...5,170,186
Ensembl chrNW_004955466:5,097,116...5,167,596
|
|
|
G |
Spta1 |
spectrin alpha, erythrocytic 1 |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis type 3 | ClinVar Annotator: match by term: Spherocytosis type 3 | ClinVar Annotator: match by term: Spherocytosis, type 3, autosomal recessive |
OMIM ClinVar |
PMID:1638030 PMID:3785322 PMID:8081008 PMID:8370581 PMID:8941647 PMID:9192783 PMID:15071791 PMID:15384986 PMID:18815189 PMID:21212007 PMID:23241237 PMID:24033266 PMID:25741868 PMID:26002053 PMID:27292444 PMID:27667160 PMID:27863252 PMID:28492532 PMID:29105823 PMID:29396846 PMID:31038472 PMID:31147440 PMID:31333484 PMID:31602632 PMID:31723846 PMID:31854503 PMID:32266426 PMID:32436265 PMID:32581362 PMID:32888494 PMID:33074880 PMID:33556202 More...
|
|
NCBI chrNW_004955468:10,472,601...10,545,402
Ensembl chrNW_004955468:10,472,671...10,545,313
|
|
|
G |
Slc4a1 |
solute carrier family 4 member 1 (Diego blood group) |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis type 4 | ClinVar Annotator: match by term: Spherocytosis type 4 |
ClinVar |
PMID:893429 PMID:1378323 PMID:1419785 PMID:1520883 PMID:1678289 PMID:1696010 PMID:1722314 PMID:1737855 PMID:2146504 PMID:2196932 PMID:2527366 PMID:6338046 PMID:7530501 PMID:7689982 PMID:7812009 PMID:7919393 PMID:7949112 PMID:8011524 PMID:8206915 PMID:8282779 PMID:8343110 PMID:8434259 PMID:8471774 PMID:8547122 PMID:8567957 PMID:8608262 PMID:8640229 PMID:8704215 PMID:8943874 PMID:9012689 PMID:9207478 PMID:9233560 PMID:9312167 PMID:9565662 PMID:9600966 PMID:9734643 PMID:9854053 PMID:9973643 PMID:10403343 PMID:10580570 PMID:10745622 PMID:10766130 PMID:10926824 PMID:10942416 PMID:11155072 PMID:11208088 PMID:11380459 PMID:12087557 PMID:12750988 PMID:12938018 PMID:14618420 PMID:16107207 PMID:16227998 PMID:16420521 PMID:17215882 PMID:18266205 PMID:19229254 PMID:19289107 PMID:19565014 PMID:19625994 PMID:20068363 PMID:20151848 PMID:20421175 PMID:20799361 PMID:21039340 PMID:22126643 PMID:22518001 PMID:22609520 PMID:23255290 PMID:23842529 PMID:24033266 PMID:24652967 PMID:25111073 PMID:25296721 PMID:25741868 PMID:26571219 PMID:26879370 PMID:27058983 PMID:27292444 PMID:28045035 PMID:28188436 PMID:28233610 PMID:28492532 PMID:28542241 PMID:29572776 PMID:29627839 PMID:29725771 PMID:30192042 PMID:30230413 PMID:31122244 PMID:31126250 PMID:31147440 PMID:31672324 PMID:31959358 PMID:32071839 PMID:32266426 PMID:32641076 PMID:32926342 PMID:33532864 PMID:34093240 PMID:34746046 PMID:35738466 PMID:35845192 PMID:36203343 PMID:36231035 PMID:37353797 More...
|
|
NCBI chrNW_004955451:17,318,600...17,330,943
Ensembl chrNW_004955451:17,315,024...17,328,103
|
|
|
G |
Epb42 |
erythrocyte membrane protein band 4.2 |
|
ISO |
ClinVar Annotator: match by term: Hereditary spherocytosis type 5 |
OMIM ClinVar |
PMID:1558976 PMID:2386772 PMID:7772513 PMID:7803799 PMID:8319790 PMID:8528207 PMID:8547071 PMID:8635206 PMID:10406914 PMID:12176912 PMID:15692067 PMID:19508687 PMID:25741868 PMID:28492532 PMID:29402830 PMID:32726712 PMID:36203343 More...
|
|
NCBI chrNW_004955416:9,784,211...9,800,453
Ensembl chrNW_004955416:9,784,260...9,798,194
|
|
|
G |
Cldn1 |
claudin 1 |
|
ISO |
ClinVar Annotator: match by term: CLDN1-related condition | ClinVar Annotator: match by term: Neonatal ichthyosis-sclerosing cholangitis syndrome |
OMIM ClinVar |
PMID:12164927 PMID:15521008 PMID:16619213 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955420:17,798,974...17,815,049
Ensembl chrNW_004955420:17,798,974...17,815,205
|
|
G |
Cldn16 |
claudin 16 |
|
ISO |
ClinVar Annotator: match by term: CLDN1-related condition | ClinVar Annotator: match by term: Neonatal ichthyosis-sclerosing cholangitis syndrome |
ClinVar |
PMID:12164927 PMID:15521008 PMID:16619213 PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955420:17,684,752...17,714,639
Ensembl chrNW_004955420:17,693,573...17,715,211
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Intrahepatic cholangiocarcinoma |
ClinVar |
PMID:24728327 PMID:25479140 PMID:25741868 PMID:26467025 PMID:26530882 PMID:28135048 PMID:28195569 PMID:28492532 PMID:32390703 More...
|
|
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression exacerbates |
ISO |
protein:decreased expression:intrahepatic bile duct (human) mRNA,protein:decreased expression:intrahepatic bile duct (human) |
RGD |
PMID:27433094 PMID:30849962 PMID:31665232 |
RGD:126775257 RGD:126781775 RGD:14974231 |
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
|
|
G |
Bap1 |
BRCA1 associated deubiquitinase 1 |
disease_progression |
ISO |
|
RGD |
PMID:27864835 |
RGD:150340628 |
NCBI chrNW_004955430:2,391,970...2,400,645
Ensembl chrNW_004955430:2,390,524...2,400,645
|
|
G |
Becn1 |
beclin 1 |
disease_progression |
ISO |
|
RGD |
PMID:30849962 |
RGD:14974231 |
NCBI chrNW_004955451:16,616,595...16,625,731
Ensembl chrNW_004955451:16,616,595...16,625,730
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
severity |
ISO |
DNA:missense mutation:cds:p.V600E (human) |
RGD |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004955494:2,567,238...2,712,708
|
|
G |
Fas |
Fas cell surface death receptor |
disease_progression |
ISO |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
Faslg |
Fas ligand |
severity |
ISO |
|
RGD |
PMID:11003620 |
RGD:14700701 |
NCBI chrNW_004955406:13,098,479...13,107,045
Ensembl chrNW_004955406:13,098,662...13,107,389
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
DNA:hypomethylation:liver |
RGD |
PMID:24291052 |
RGD:38599002 |
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
|
|
G |
Hsp90aa1 |
heat shock protein 90 alpha family class A member 1 |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004955538:1,469,544...1,475,010
Ensembl chrNW_004955538:1,469,544...1,475,019
|
|
G |
Hsp90ab1 |
heat shock protein 90 alpha family class B member 1 |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004955437:9,872,649...9,878,459
Ensembl chrNW_004955437:9,873,908...9,878,459
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
no_association |
ISO |
DNA:misssense mutations:cds:p.Arg132Cys,Arg132Leu (human) |
RGD |
PMID:26245674 |
RGD:14974229 |
NCBI chrNW_004955457:6,851,542...6,869,452
Ensembl chrNW_004955457:6,851,517...6,872,367
|
|
G |
Idh2 |
isocitrate dehydrogenase (NADP(+)) 2 |
disease_progression |
ISO |
DNA:mutations: : mRNA:decreased expression:liver (mouse) |
RGD |
PMID:22824796 PMID:32463951 |
RGD:149735894 RGD:14985256 |
NCBI chrNW_004955416:15,197,611...15,212,919
Ensembl chrNW_004955416:15,197,366...15,223,363
|
|
G |
Kdm5c |
lysine demethylase 5C |
exacerbates |
ISO |
protein:decreased expression:bile duct (human) |
RGD |
PMID:32714863 |
RGD:151361175 |
NCBI chrNW_004955475:243,666...278,064
Ensembl chrNW_004955475:243,666...278,627
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO |
DNA:mutations:: |
RGD MouseDO |
PMID:24139215 |
RGD:14398746 |
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
|
|
G |
Lrp1b |
LDL receptor related protein 1B |
exacerbates |
ISO |
DNA:mutations:multiple: (human) |
RGD |
PMID:33014052 |
RGD:150429786 |
NCBI chrNW_004955440:7,048,527...8,475,566
Ensembl chrNW_004955440:7,050,135...8,475,122
|
|
G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chrNW_004955517:54,699...654,398
Ensembl chrNW_004955517:55,091...655,638
|
|
G |
Pbrm1 |
polybromo 1 |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:27864835 PMID:30377796 |
RGD:150340628 RGD:152998946 |
NCBI chrNW_004955430:2,536,086...2,671,094
Ensembl chrNW_004955430:2,536,086...2,670,617
|
|
G |
Pten |
phosphatase and tensin homolog |
disease_progression |
ISO |
protein:decreased expression:liver (human) |
RGD |
PMID:24796583 |
RGD:152177907 |
NCBI chrNW_004955425:5,007,811...5,091,829
Ensembl chrNW_004955425:5,014,147...5,091,829
|
|
G |
Rnf43 |
ring finger protein 43 |
exacerbates |
ISO |
mRNA, protein:decreased expression:liver, bile duct epithelium (human) |
RGD |
PMID:26980022 |
RGD:151361125 |
NCBI chrNW_004955451:4,604,985...4,680,762
Ensembl chrNW_004955451:4,604,985...4,680,762
|
|
G |
S100b |
S100 calcium binding protein B |
disease_progression |
ISO |
protein:increased expression:intrahepatic bile duct (human) |
RGD |
PMID:30377796 |
RGD:152998946 |
NCBI chrNW_004955407:42,972,584...42,980,510
Ensembl chrNW_004955407:42,972,584...42,980,510
|
|
G |
Smad4 |
SMAD family member 4 |
disease_progression |
ISO |
mRNA,protein:decreased expression:intrahepatic bile duct |
RGD |
PMID:16917866 PMID:23981608 |
RGD:18936999 RGD:21066336 |
NCBI chrNW_004955402:35,956,080...36,001,746
Ensembl chrNW_004955402:35,961,165...35,994,538
|
|
G |
Tep1 |
telomerase associated protein 1 |
|
ISO |
mRNA:increased expression:hepatocyte,biliary epithelium. |
RGD |
PMID:10498642 |
RGD:152977753 |
NCBI chrNW_004955550:1,162,067...1,215,746
Ensembl chrNW_004955550:1,162,186...1,215,723
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Progressive intrahepatic cholestasis |
RGD ClinVar |
PMID:9806540 PMID:10579978 PMID:12370274 PMID:12717091 PMID:15300568 PMID:16039748 PMID:16290310 PMID:16641580 PMID:16871584 PMID:17855769 PMID:18395098 PMID:18692205 PMID:19101985 PMID:19750581 PMID:19845854 PMID:20232290 PMID:20414253 PMID:20583290 PMID:20683201 PMID:21404481 PMID:21490445 PMID:22364601 PMID:24231640 PMID:24339557 PMID:24402531 PMID:24627769 PMID:25741868 PMID:26382629 PMID:26678486 PMID:26858187 PMID:27050426 PMID:27114171 PMID:27239116 PMID:27426735 PMID:28027573 PMID:28119944 PMID:28492532 PMID:28733223 PMID:29104077 PMID:29412511 PMID:30210030 PMID:31745229 PMID:32087350 PMID:32309332 PMID:32581362 PMID:32808743 PMID:32860008 PMID:33215027 PMID:33915153 PMID:34016879 PMID:35257483 More...
|
RGD:1598583 |
NCBI chrNW_004955449:5,412,958...5,511,629
Ensembl chrNW_004955449:5,412,876...5,512,701
|
|
G |
Ap1s1 |
adaptor related protein complex 1 subunit sigma 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23423674 |
|
NCBI chrNW_004955456:16,127,877...16,134,039
Ensembl chrNW_004955456:16,127,877...16,134,039
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
susceptibility |
ISO |
DNA:mutation ClinVar Annotator: match by term: Progressive intrahepatic cholestasis |
RGD ClinVar |
PMID:5807632 PMID:9500542 PMID:9918928 PMID:11815775 PMID:14988830 PMID:15239083 PMID:19260995 PMID:19731236 PMID:19918981 PMID:20232290 PMID:20414253 PMID:22525741 PMID:25741868 PMID:26382629 PMID:26678486 PMID:26858187 PMID:26879107 PMID:28492532 PMID:28733223 PMID:30366773 PMID:31450232 PMID:33437900 PMID:33666275 PMID:34016879 More...
|
RGD:1599397 |
NCBI chrNW_004955402:41,994,993...42,113,380
Ensembl chrNW_004955402:41,996,001...42,113,895
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:24493287 |
RGD:26884361 |
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18364083 PMID:22094456 |
|
NCBI chrNW_004955418:2,001,509...2,005,269
Ensembl chrNW_004955418:2,002,699...2,005,007
|
|
G |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
|
ISO |
protein:decreased activity,altered location:liver: |
RGD |
PMID:11383876 |
RGD:9685454 |
NCBI chrNW_004955507:2,035,918...2,141,327
Ensembl chrNW_004955507:2,036,050...2,137,377
|
|
G |
Hsd3b7 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 |
|
ISO |
CBAS1, OMIM:607765 |
RGD |
PMID:12679481 |
RGD:1599971 |
NCBI chrNW_004955493:7,835,160...7,838,428
Ensembl chrNW_004955493:7,835,160...7,838,428
|
|
G |
LOC102026028 |
cytochrome P450 2E1 |
|
ISO |
|
RGD |
PMID:29404441 |
RGD:14700873 |
NCBI chrNW_004955507:6,293,162...6,303,255
Ensembl chrNW_004955507:6,289,576...6,304,193
|
|
G |
Maf |
MAF bZIP transcription factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20146260 |
|
NCBI chrNW_004955522:2,514,313...2,519,694
|
|
G |
Mafg |
MAF bZIP transcription factor G |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20146260 |
|
NCBI chrNW_004955506:1,247,294...1,252,167
Ensembl chrNW_004955506:1,247,293...1,252,167
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0 group B member 2 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:18578998 |
RGD:2311605 |
NCBI chrNW_004955452:6,251,047...6,253,541
Ensembl chrNW_004955452:6,250,889...6,254,541
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1 group H member 4 |
|
ISO |
|
RGD |
PMID:15644430 |
RGD:1625202 |
NCBI chrNW_004955405:36,160,360...36,236,258
Ensembl chrNW_004955405:36,160,049...36,237,751
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
mRNA, protein:decreased expression:kidney |
RGD |
PMID:19002567 |
RGD:7243885 |
NCBI chrNW_004955439:20,567,241...20,608,281
Ensembl chrNW_004955439:20,567,212...20,609,105
|
|
G |
Tjp2 |
tight junction protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24614073 |
|
NCBI chrNW_004955434:3,781,368...3,923,240
Ensembl chrNW_004955434:3,781,113...3,923,391
|
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chrNW_004955402:41,994,993...42,113,380
Ensembl chrNW_004955402:41,996,001...42,113,895
|
|
G |
Hdac3 |
histone deacetylase 3 |
severity |
ISO |
|
RGD |
PMID:28697498 |
RGD:14696655 |
NCBI chrNW_004955415:12,138,520...12,154,234
Ensembl chrNW_004955415:12,138,870...12,154,234
|
|
G |
Il18 |
interleukin 18 |
severity |
ISO |
|
RGD |
PMID:28697498 |
RGD:14696655 |
NCBI chrNW_004955412:13,807,361...13,826,007
Ensembl chrNW_004955412:13,806,553...13,825,634
|
|
G |
Tnf |
tumor necrosis factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23627780 |
|
NCBI chrNW_004955437:117,267...119,899
Ensembl chrNW_004955437:117,206...120,700
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28851649 |
|
NCBI chrNW_004955435:5,390,745...5,410,025
Ensembl chrNW_004955435:5,390,751...5,411,691
|
|
|
G |
Atp8b1 |
ATPase phospholipid transporting 8B1 |
|
ISO |
ClinVar Annotator: match by term: CHOLESTASIS, PREGNANCY-RELATED, 1 | ClinVar Annotator: match by term: Cholestasis, intrahepatic, of pregnancy, 1 |
OMIM ClinVar |
PMID:15239083 PMID:15657619 PMID:15888793 PMID:19731236 PMID:20038848 PMID:20981092 PMID:22525741 PMID:22995991 PMID:24033266 PMID:24260417 PMID:25741868 PMID:26126923 PMID:28492532 PMID:28733223 PMID:28924228 PMID:29238877 PMID:32650689 PMID:32695736 PMID:33223529 PMID:35894240 More...
|
|
NCBI chrNW_004955402:41,994,993...42,113,380
Ensembl chrNW_004955402:41,996,001...42,113,895
|
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
|
ISO |
ClinVar Annotator: match by term: Cholestasis, intrahepatic, of pregnancy, 3 |
ClinVar |
PMID:9806540 PMID:10579978 PMID:12370274 PMID:12717091 PMID:15300568 PMID:16039748 PMID:16871584 PMID:17855769 PMID:18395098 PMID:18692205 PMID:19101985 PMID:19750581 PMID:20232290 PMID:20583290 PMID:20683201 PMID:23022423 PMID:23279303 PMID:23750872 PMID:24231640 PMID:24339557 PMID:24402531 PMID:25741868 PMID:26126923 PMID:26858187 PMID:27050426 PMID:27153395 PMID:27426735 PMID:28492532 PMID:28733223 PMID:29104077 PMID:29412511 PMID:29992621 PMID:30091450 PMID:30934130 PMID:31538484 PMID:31745229 PMID:32309332 PMID:32581362 PMID:32808743 PMID:34016879 More...
|
|
NCBI chrNW_004955449:5,412,958...5,511,629
Ensembl chrNW_004955449:5,412,876...5,512,701
|
|
|
G |
Pkhd1 |
PKHD1 ciliary IPT domain containing fibrocystin/polyductin |
|
ISO |
ClinVar Annotator: match by term: Cystic dilatation of the intrahepatic biliary tree |
ClinVar |
PMID:1189128 PMID:11898128 PMID:12874454 PMID:15698423 PMID:15805161 PMID:16133180 PMID:19914852 PMID:20413436 PMID:25701400 PMID:25741868 PMID:26695994 PMID:27151922 PMID:27225849 PMID:27894351 PMID:28492532 PMID:29068549 PMID:31130284 PMID:31844813 PMID:31980526 PMID:32359821 PMID:32398770 PMID:32571524 PMID:32574212 PMID:32799815 PMID:35715958 More...
|
|
NCBI chrNW_004955411:5,988,100...6,434,369
Ensembl chrNW_004955411:5,990,316...6,432,301
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Klatskin tumor |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
G |
Arid1a |
AT-rich interaction domain 1A |
disease_progression |
ISO |
DNA:deletions |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955452:6,068,631...6,120,759
Ensembl chrNW_004955452:6,068,631...6,120,759
|
|
G |
Kmt2c |
lysine methyltransferase 2C |
onset |
ISO |
DNA:mutations |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955491:6,245,408...6,420,535
Ensembl chrNW_004955491:6,247,249...6,402,470
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
disease_progression |
ISO |
DNA:mutations |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955413:20,298,852...20,328,756
Ensembl chrNW_004955413:20,298,824...20,328,758
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
sexual_dimorphism |
ISO |
DNA:substitutions, insertion/deletions: (human) |
RGD |
PMID:33387086 |
RGD:126848756 |
NCBI chrNW_004955444:11,154,318...11,414,680
Ensembl chrNW_004955444:11,154,318...11,414,075
|
|
|
G |
Vps50 |
VPS50 subunit of EARP/GARPII complex |
|
ISO |
ClinVar Annotator: match by term: Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis |
OMIM ClinVar |
PMID:25741868 PMID:34037727 |
|
NCBI chrNW_004955432:10,134,280...10,244,390
Ensembl chrNW_004955432:10,134,141...10,245,895
|
|
|
G |
Utp4 |
UTP4 small subunit processome component |
|
ISO |
ClinVar Annotator: match by term: Hereditary North American Indian childhood cirrhosis |
ClinVar |
PMID:9536098 PMID:12417987 PMID:16225863 PMID:17576681 PMID:19732766 PMID:20385600 PMID:22916032 PMID:24123366 PMID:25741868 PMID:27535533 PMID:28492532 More...
|
|
NCBI chrNW_004955484:7,501,784...7,531,757
Ensembl chrNW_004955484:7,500,613...7,531,198
|
|
|
G |
Adm |
adrenomedullin |
|
ISO |
protein:increased expression:plasma: |
RGD |
PMID:20132852 |
RGD:7364952 |
NCBI chrNW_004955414:25,951,473...25,953,593
Ensembl chrNW_004955414:25,951,349...25,953,645
|
|
G |
Alb |
albumin |
|
ISO |
|
RGD |
PMID:9161836 |
RGD:11036102 |
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Cd14 |
CD14 molecule |
|
ISO |
mRNA:increased expression:ileum, liver, lung, spleen |
RGD |
PMID:25093541 |
RGD:9685190 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
|
ISO |
|
RGD |
PMID:9161836 |
RGD:11036102 |
NCBI chrNW_004955454:3,127,997...3,132,459
Ensembl chrNW_004955454:3,127,997...3,132,459
|
|
G |
Hmbs |
hydroxymethylbilane synthase |
|
ISO |
Protein:increased activity:liver (rat) |
RGD |
PMID:3963818 |
RGD:4144803 |
NCBI chrNW_004955412:20,192,519...20,202,635
Ensembl chrNW_004955412:20,192,522...20,202,635
|
|
G |
Hmgb1 |
high mobility group box 1 |
|
ISO |
protein:increased expression:liver, plasma |
RGD |
PMID:21737101 |
RGD:10402168 |
NCBI chrNW_004955431:15,373,207...15,377,339
Ensembl chrNW_004955431:15,373,207...15,377,339
|
|
G |
Pcna |
proliferating cell nuclear antigen |
treatment |
ISO |
|
RGD |
PMID:12917765 |
RGD:10448973 |
NCBI chrNW_004955415:15,744,601...15,748,910
Ensembl chrNW_004955415:15,744,601...15,749,673
|
|
G |
Tlr2 |
toll like receptor 2 |
treatment |
ISO |
|
RGD |
PMID:29366780 |
RGD:15090858 |
NCBI chrNW_004955471:8,011,710...8,019,063
Ensembl chrNW_004955471:8,014,910...8,017,258
|
|
G |
Ucp2 |
uncoupling protein 2 |
|
ISO |
|
RGD |
PMID:19632092 |
RGD:7204429 |
NCBI chrNW_004955414:17,592,914...17,596,477
Ensembl chrNW_004955414:17,592,914...17,596,477
|
|
|
G |
Unc45a |
unc-45 myosin chaperone A |
|
ISO |
ClinVar Annotator: match by term: Osteootohepatoenteric syndrome |
OMIM ClinVar |
PMID:25741868 PMID:28492532 PMID:29429573 PMID:31231135 PMID:35575086 |
|
NCBI chrNW_004955416:14,999,692...15,012,581
Ensembl chrNW_004955416:14,999,375...15,012,581
|
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
|
ISO |
ClinVar Annotator: match by term: Periampullary adenoma |
ClinVar |
PMID:25741868 PMID:27087319 PMID:28492532 PMID:32860008 |
|
NCBI chrNW_004955418:2,567,804...2,675,062
Ensembl chrNW_004955418:2,566,975...2,674,832
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:28660384 |
RGD:21203516 |
NCBI chrNW_004955419:21,553,863...21,681,626
Ensembl chrNW_004955419:21,553,835...21,681,619
|
|
G |
Abcc2 |
ATP binding cassette subfamily C member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:decreased expression:liver |
CTD RGD |
PMID:15542527 PMID:15770136 |
RGD:14700810 |
NCBI chrNW_004955507:5,724,788...5,791,281
Ensembl chrNW_004955507:5,724,762...5,790,812
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 (JR blood group) |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15542527 |
|
NCBI chrNW_004955474:12,365,903...12,408,715
|
|
G |
Ace2 |
angiotensin converting enzyme 2 |
|
ISO |
mRNA, protein:increased expression:liver |
RGD |
PMID:17532087 |
RGD:9685452 |
NCBI chrNW_004955519:2,591,229...2,643,705
Ensembl chrNW_004955519:2,591,248...2,633,495
|
|
G |
Agt |
angiotensinogen |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:17532087 |
RGD:9685452 |
NCBI chrNW_004955492:7,863,662...7,874,863
Ensembl chrNW_004955492:7,866,833...7,873,357
|
|
G |
Alb |
albumin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955447:9,327...21,212
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
|
RGD |
PMID:20451280 |
RGD:5148030 |
NCBI chrNW_004955772:1,160...10,709
Ensembl chrNW_004955772:1,159...10,709
|
|
G |
Ca1 |
carbonic anhydrase 1 |
|
ISO |
|
RGD |
PMID:12806141 |
RGD:408425977 |
NCBI chrNW_004955417:3,270,619...3,313,261
Ensembl chrNW_004955417:3,270,619...3,305,756
|
|
G |
Ca2 |
carbonic anhydrase 2 |
|
ISO |
|
RGD |
PMID:12806141 |
RGD:408425977 |
NCBI chrNW_004955417:3,388,110...3,402,798
Ensembl chrNW_004955417:3,386,087...3,402,363
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
ISO |
mRNA:increased expression:liver: CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:12126966 PMID:15770052 |
RGD:14995336 |
NCBI chrNW_004955481:10,293,758...10,301,118
Ensembl chrNW_004955481:10,293,399...10,301,143
|
|
G |
Ccn2 |
cellular communication network factor 2 |
|
ISO |
mRNA:increased expression:liver (rat) |
RGD |
PMID:19371232 |
RGD:2314517 |
NCBI chrNW_004955436:12,523,602...12,526,986
Ensembl chrNW_004955436:12,522,944...12,526,480
|
|
G |
Cd14 |
CD14 molecule |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:21275501 |
RGD:407420272 |
NCBI chrNW_004955418:73,736...75,345
Ensembl chrNW_004955418:73,897...75,224
|
|
G |
Cd3d |
CD3d molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18422935 |
|
NCBI chrNW_004955412:19,481,059...19,484,890
Ensembl chrNW_004955412:19,480,977...19,484,721
|
|
G |
Cd68 |
CD68 molecule |
disease_progression |
ISO |
protein:increased expression:liver (human) |
RGD |
PMID:21275501 |
RGD:407420272 |
NCBI chrNW_004955467:9,340,490...9,343,912
Ensembl chrNW_004955467:9,341,364...9,343,836
|
|
G |
Cd80 |
CD80 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21399635 |
|
NCBI chrNW_004955427:19,237,251...19,274,001
Ensembl chrNW_004955427:19,236,445...19,261,517
|
|
G |
Cdh5 |
cadherin 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18422935 |
|
NCBI chrNW_004955433:22,957,718...22,994,515
Ensembl chrNW_004955433:22,967,960...22,992,924
|
|
G |
Cdkn1a |
cyclin dependent kinase inhibitor 1A |
|
ISO |
protein:increased expression:epithelial cell: |
RGD |
PMID:18456456 |
RGD:8662434 |
NCBI chrNW_004955437:6,254,638...6,261,278
Ensembl chrNW_004955437:6,254,309...6,261,479
|
|
G |
Cenpb |
centromere protein B |
|
ISO |
|
RGD |
PMID:8911074 |
RGD:27226708 |
NCBI chrNW_004955415:14,626,154...14,628,749
Ensembl chrNW_004955415:14,626,949...14,628,748
|
|
G |
Clec16a |
C-type lectin domain containing 16A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21399635 |
|
NCBI chrNW_004955442:7,369,616...7,584,052
Ensembl chrNW_004955442:7,368,952...7,584,703
|
|
G |
Col1a1 |
collagen type I alpha 1 chain |
treatment |
ISO |
|
RGD |
PMID:20056896 |
RGD:8552731 |
NCBI chrNW_004955451:11,468,156...11,484,410
Ensembl chrNW_004955451:11,468,290...11,483,073
|
|
G |
Cpeb1 |
cytoplasmic polyadenylation element binding protein 1 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:26627607 |
RGD:11528851 |
NCBI chrNW_004955416:13,963,300...14,038,691
Ensembl chrNW_004955416:13,981,657...14,039,705
|
|
G |
Cpeb4 |
cytoplasmic polyadenylation element binding protein 4 |
|
ISO |
protein:increased expression:liver |
RGD |
PMID:26627607 |
RGD:11528851 |
NCBI chrNW_004955408:26,535,281...26,597,317
Ensembl chrNW_004955408:26,535,281...26,597,547
|
|
G |
Ctla4 |
cytotoxic T-lymphocyte associated protein 4 |
susceptibility disease_progression no_association |
ISO |
autoimmune biliary cirrhosis; DNA:SNP:CDS:49A>G, significant association with G allele (p<0.0002) DNA:SNP:CDS:60G>A(rs3087243)(human) DNA:SNPs: :rs231775, rs3087243, rs231725 (human) DNA:SNP:CDS:49A>G(human) |
RGD |
PMID:10782900 PMID:16584111 PMID:17482523 PMID:21594562 |
RGD:14398725 RGD:14398743 RGD:14398744 RGD:2301998 |
NCBI chrNW_004955457:11,028,707...11,034,898
Ensembl chrNW_004955457:11,028,698...11,073,460
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18422935 |
|
NCBI chrNW_004955433:748,392...750,890
Ensembl chrNW_004955433:748,284...750,927
|
|
G |
Cxcl8 |
C-X-C motif chemokine ligand 8 |
|
ISO |
mRNA:increased expression:liver (human) |
RGD |
PMID:21731723 |
RGD:26884357 |
NCBI chrNW_004955474:247,326...250,355
Ensembl chrNW_004955474:241,501...250,643
|
|
G |
Cxcl9 |
C-X-C motif chemokine ligand 9 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18422935 |
|
NCBI chrNW_004955433:724,566...731,945
Ensembl chrNW_004955433:724,515...732,192
|
|
G |
Cxcr5 |
C-X-C motif chemokine receptor 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21399635 |
|
NCBI chrNW_004955412:20,016,768...20,031,635
Ensembl chrNW_004955412:20,016,587...20,031,629
|
|
G |
Cygb |
cytoglobin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955506:5,766,006...5,775,722
Ensembl chrNW_004955506:5,766,006...5,775,784
|
|
G |
Dag1 |
dystroglycan 1 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:12177244 |
RGD:2314895 |
NCBI chrNW_004955532:1,446,553...1,465,310
Ensembl chrNW_004955532:1,397,900...1,466,312
|
|
G |
Dennd1b |
DENN domain containing 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21399635 |
|
NCBI chrNW_004955406:34,021,508...34,241,735
Ensembl chrNW_004955406:34,027,046...34,241,737
|
|
G |
Dnase1 |
deoxyribonuclease 1 |
|
ISO |
protein:decreased activity:serum (human) |
RGD |
PMID:28263100 |
RGD:38500241 |
NCBI chrNW_004955442:13,733,107...13,736,527
|
|
G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:15651265 |
RGD:9685530 |
NCBI chrNW_004955513:5,070,050...5,075,098
Ensembl chrNW_004955513:5,068,875...5,075,098
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
protein:increased expression:lymphocyte: |
RGD |
PMID:26429926 |
RGD:14700711 |
NCBI chrNW_004955425:3,961,671...3,987,513
Ensembl chrNW_004955425:3,961,013...3,987,455
|
|
G |
Foxp3 |
forkhead box P3 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:17158635 |
RGD:38501106 |
NCBI chrNW_004955543:731,707...742,606
Ensembl chrNW_004955543:731,707...742,606
|
|
G |
Gch1 |
GTP cyclohydrolase 1 |
treatment |
ISO |
|
RGD |
PMID:20132096 |
RGD:329970291 |
NCBI chrNW_004955409:8,624,225...8,670,436
Ensembl chrNW_004955409:8,624,468...8,668,614
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
treatment |
ISO |
mRNA:decreased expression:liver |
RGD |
PMID:19652645 PMID:23704825 |
RGD:11041639 RGD:11041732 |
NCBI chrNW_004955468:4,576,080...4,577,591
Ensembl chrNW_004955468:4,575,510...4,577,649
|
|
G |
Hhip |
hedgehog interacting protein |
|
ISO |
mRNA:decreased expression: |
RGD |
PMID:18375471 |
RGD:11552599 |
NCBI chrNW_004955428:657,918...745,255
Ensembl chrNW_004955428:657,900...745,250
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22271822 |
|
NCBI chrNW_004955466:8,000,311...8,022,497
Ensembl chrNW_004955466:8,000,044...8,022,497
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
mRNA, protein:increased expression:liver, lung |
RGD |
PMID:12114196 |
RGD:625603 |
NCBI chrNW_004955405:43,124,447...43,128,873
Ensembl chrNW_004955405:43,124,510...43,130,979
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
treatment |
ISO |
associated with Graft vs Host Disease; |
RGD |
PMID:10051478 |
RGD:11520783 |
NCBI chrNW_004955495:1,561,464...1,573,282
Ensembl chrNW_004955495:1,561,714...1,574,755
|
|
G |
Ifng |
interferon gamma |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:17158635 |
RGD:38501106 |
NCBI chrNW_004955458:14,643,333...14,648,020
Ensembl chrNW_004955458:14,643,313...14,648,045
|
|
G |
Igfbp1 |
insulin like growth factor binding protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18422935 |
|
NCBI chrNW_004955456:6,810,461...6,814,944
Ensembl chrNW_004955456:6,810,056...6,815,685
|
|
G |
Il10 |
interleukin 10 |
|
ISO |
mRNA:increased expression:liver |
RGD |
PMID:17158635 |
RGD:38501106 |
NCBI chrNW_004955406:42,307,789...42,312,255
Ensembl chrNW_004955406:42,307,664...42,312,779
|
|
G |
Il12a |
interleukin 12A |
susceptibility treatment |
ISO |
DNA:SNPs, haplotype: :rs6441286, rs574808(human) DNA:SNPs:enhancer:rs4679868, rs6441286, rs666251(human) DNA:SNP: :rs62270414(human) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:19458352 PMID:20639880 PMID:23433321 PMID:27175695 |
RGD:25440489 RGD:25440498 RGD:25440500 |
NCBI chrNW_004955448:10,611,131...10,617,911
|
|
G |
Il12b |
interleukin 12B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20639880 |
|
NCBI chrNW_004955408:13,302,506...13,316,300
Ensembl chrNW_004955408:13,304,219...13,312,620
|
|
G |
Il12rb1 |
interleukin 12 receptor subunit beta 1 |
susceptibility |
ISO |
RNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:23910013 |
RGD:14700865 |
NCBI chrNW_004955524:3,276,932...3,299,617
|
|
G |
Il1b |
interleukin 1 beta |
disease_progression |
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:21275501 |
RGD:407420272 |
NCBI chrNW_004955470:1,486,936...1,491,888
Ensembl chrNW_004955470:1,486,967...1,491,947
|
|
G |
Il4 |
interleukin 4 |
treatment |
ISO |
|
RGD |
PMID:20442198 |
RGD:7829828 |
NCBI chrNW_004955408:4,058,052...4,065,999
|
|
G |
Il6 |
interleukin 6 |
disease_progression |
ISO |
protein:increased expression:blood serum (human) |
RGD |
PMID:21275501 |
RGD:407420272 |
NCBI chrNW_004955410:25,079,835...25,084,390
|
|
G |
Il7r |
interleukin 7 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21399635 |
|
NCBI chrNW_004955426:20,785,896...20,818,512
Ensembl chrNW_004955426:20,787,471...20,818,577
|
|
G |
Jak2 |
Janus kinase 2 |
treatment |
ISO |
|
RGD |
PMID:24619965 |
RGD:10403061 |
NCBI chrNW_004955434:9,227,897...9,341,208
Ensembl chrNW_004955434:9,227,595...9,341,208
|
|
G |
Keap1 |
kelch like ECH associated protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955495:1,704,695...1,711,339
Ensembl chrNW_004955495:1,704,695...1,711,290
|
|
G |
Krt18 |
keratin 18 |
severity |
ISO |
protein:increased expression:serum (human) |
RGD |
PMID:26110613 |
RGD:18337483 |
NCBI chrNW_004955458:227,017...230,752
Ensembl chrNW_004955458:226,805...232,728
|
|
G |
Krt7 |
keratin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21681009 |
|
NCBI chrNW_004955547:2,584,425...2,598,770
Ensembl chrNW_004955547:2,533,377...2,598,833
|
|
G |
Lbr |
lamin B receptor |
|
ISO |
|
RGD |
PMID:8550049 |
RGD:9588625 |
NCBI chrNW_004955520:401,733...418,279
|
|
G |
Lep |
leptin |
|
ISO |
protein:decreased expression:serum: |
RGD |
PMID:16093869 |
RGD:10411894 |
NCBI chrNW_004955479:9,266,604...9,276,568
Ensembl chrNW_004955479:9,274,516...9,279,472
|
|
G |
Lepr |
leptin receptor |
|
ISO |
protein:increased expression:blood serum |
RGD |
PMID:16093869 |
RGD:10411894 |
NCBI chrNW_004955423:25,108,897...25,185,315
Ensembl chrNW_004955423:25,111,266...25,185,407
|
|
G |
Lox |
lysyl oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16023247 |
|
NCBI chrNW_004955521:178,290...193,926
Ensembl chrNW_004955521:185,792...193,926
|
|
G |
Loxl2 |
lysyl oxidase like 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16023247 |
|
NCBI chrNW_004955403:46,503,226...46,583,807
Ensembl chrNW_004955403:46,504,440...46,584,016
|
|
G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
|
ISO |
OMIM:109720 | OMIM:613007 | OMIM:613008 | OMIM:614220 | OMIM:614221 |
MouseDO |
|
|
NCBI chrNW_004955451:17,907,800...17,954,821
Ensembl chrNW_004955451:17,908,827...17,926,151
|
|
G |
Mapk14 |
mitogen-activated protein kinase 14 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955437:3,836,331...3,884,083
Ensembl chrNW_004955437:3,838,232...3,884,083
|
|
G |
Mas1 |
MAS1 proto-oncogene, G protein-coupled receptor |
|
ISO |
|
RGD |
PMID:17532087 |
RGD:9685452 |
NCBI chrNW_004955439:20,956,862...20,957,839
Ensembl chrNW_004955439:20,956,862...20,957,839
|
|
G |
Met |
MET proto-oncogene, receptor tyrosine kinase |
severity |
ISO |
|
RGD |
PMID:19208365 |
RGD:14694826 |
NCBI chrNW_004955432:22,440,671...22,519,592
Ensembl chrNW_004955432:22,440,637...22,517,647
|
|
G |
Mmel1 |
membrane metalloendopeptidase like 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20639879 |
|
NCBI chrNW_004955486:8,635,727...8,662,793
Ensembl chrNW_004955486:8,638,233...8,663,053
|
|
G |
Mmp13 |
matrix metallopeptidase 13 |
treatment |
ISO |
|
RGD |
PMID:20056896 |
RGD:8552731 |
NCBI chrNW_004955412:6,106,994...6,118,760
Ensembl chrNW_004955412:6,106,994...6,118,760
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
treatment |
ISO |
|
RGD |
PMID:20056896 |
RGD:8552731 |
NCBI chrNW_004955433:13,024,844...13,050,041
Ensembl chrNW_004955433:13,024,418...13,052,775
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
|
RGD |
PMID:20056896 |
RGD:8552731 |
NCBI chrNW_004955445:11,295,500...11,303,322
Ensembl chrNW_004955445:11,295,448...11,303,288
|
|
G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
ISO |
|
RGD |
PMID:18507686 |
RGD:2324885 |
NCBI chrNW_004955476:11,108,826...11,135,697
Ensembl chrNW_004955476:11,108,826...11,135,697
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30026087 |
|
NCBI chrNW_004955403:19,510,122...19,536,428
Ensembl chrNW_004955403:19,532,103...19,535,944
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21399635 |
|
NCBI chrNW_004955496:5,842,734...5,950,995
Ensembl chrNW_004955496:5,842,600...5,927,885
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression, increased activity:brain (rat) |
CTD RGD |
PMID:21903766 PMID:30026087 |
RGD:5509055 |
NCBI chrNW_004955481:5,197,957...5,232,406
Ensembl chrNW_004955481:5,201,234...5,231,961
|
|
|